Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Int J Cardiol
    June 2024
  1. MCCHORD J, Ong P
    Advancing precision medicine in INOCA research: The INOCA-IT registry.
    Int J Cardiol. 2024;404:131975.
    >> Share

  2. SHIBA M, Kato T, Seko Y, Minamino-Muta E, et al
    Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates cardiac dysfunction in long-term fasting mice.
    Int J Cardiol. 2024;404:131972.
    >> Share

  3. STERPETTI AV, Gabriele R, Di Marzo L
    Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome.
    Int J Cardiol. 2024;404:131937.
    >> Share

  4. BACIGALUPI E, Pelliccia F, Zimarino M
    Diabetes mellitus and in-stent restenosis: A direct link or something more?
    Int J Cardiol. 2024;404:131922.
    >> Share

  5. GOLINO M, Harding D, Del Buono MG, Fanti S, et al
    Innate and adaptive immunity in acute myocarditis.
    Int J Cardiol. 2024;404:131901.
    >> Share

    May 2024
  6. SAMPAIO RODRIGUES T, Narendren A, Cailes B, Lim RP, et al
    Enhancing pre-transplant cardiac assessment: Validation and utility of the CAD-LT score with CCTA in liver transplant candidates.
    Int J Cardiol. 2024;403:131895.
    >> Share

  7. XU P, Cao Y, Zhang S, Liu X, et al
    The predictive value of serum Dickkopf-1, Dickkopf-3 level to coronary artery disease and acute coronary syndrome.
    Int J Cardiol. 2024;403:131887.
    >> Share

  8. DOUGHTY A, Keane G, Wadley AJ, Mahoney B, et al
    Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation.
    Int J Cardiol. 2024;403:131888.
    >> Share

  9. DE ALENCAR NETO JN, Scheffer MK, Correia BP, Franchini KG, et al
    Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion.
    Int J Cardiol. 2024;402:131889.
    >> Share

  10. OLSEN FJ, Smiseth OA, Biering-Sorensen T
    Improving post-MI risk stratification with pressure-strain loops: Work in progress.
    Int J Cardiol. 2024;402:131866.
    >> Share

  11. DI VITO L, Di Giusto F, Grossi P
    Non-culprit plaque progression: What do we know?
    Int J Cardiol. 2024;402:131881.
    >> Share

  12. GHIZZONI G, Leone AM, di Serafino L, Galante D, et al
    "The INOCA-IT: Rationale and design of a multicenter registry investigating ischemia in patients with non-obstructive coronary artery (INOCA) disease in Italy".
    Int J Cardiol. 2024;402:131859.
    >> Share

  13. AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
    Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
    Int J Cardiol. 2024;402:131819.
    >> Share

    April 2024
  14. ANDO G, Lombardo L, Alagna G, Micari A, et al
    Monotherapy with P2Y(12)-inhibitors after dual antiplatelet therapy: Filling gaps in evidence.
    Int J Cardiol. 2024;401:131893.
    >> Share

  15. BRUNO F, de Filippo O, Sardone A, Capranzano P, et al
    Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study.
    Int J Cardiol. 2024;401:131861.
    >> Share

  16. HAN D, Hyun MC, Miller RJH, Gransar H, et al
    10-year experience of utilizing a stress-first SPECT myocardial perfusion imaging.
    Int J Cardiol. 2024;401:131863.
    >> Share

  17. TANNER R, Farhan S, Giustino G, Sartori S, et al
    Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry.
    Int J Cardiol. 2024;401:131856.
    >> Share

  18. XIA B, Lu Y, Liang J, Li F, et al
    Association of GAL-8 promoter methylation levels with coronary plaque inflammation.
    Int J Cardiol. 2024;401:131782.
    >> Share

  19. RIEHLE C, Sieweke JT, Udesen NLJ, Helgestad OKL, et al
    Circulating biomarkers of the CS4P and CLIP scores are not altered in a pig model of acute cardiogenic shock and additional short-term circulatory support.
    Int J Cardiol. 2024;401:131699.
    >> Share

  20. WOLF S, Schievano E, Amidei CB, Kucher N, et al
    Mortality trend of ischemic heart disease (2008-2022): A retrospective analysis of epidemiological data.
    Int J Cardiol. 2024 Apr 12:132042. doi: 10.1016/j.ijcard.2024.132042.
    >> Share

  21. YANG J, Zhao Y, Wang J, Ma L, et al
    Current status of emergency medical service use in ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry.
    Int J Cardiol. 2024 Apr 11:132040. doi: 10.1016/j.ijcard.2024.132040.
    >> Share

  22. UELAND T, Butt N, Lekva T, Orn S, et al
    High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction.
    Int J Cardiol. 2024 Apr 9:132035. doi: 10.1016/j.ijcard.2024.132035.
    >> Share

  23. YILDIRIM M, Giannitsis E, Mueller-Hennessen M
    Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
    Int J Cardiol. 2024 Apr 6:132030. doi: 10.1016/j.ijcard.2024.132030.
    >> Share

  24. ZHAO J, Wu T, Tan J, Chen Y, et al
    Pancoronary plaque characteristics in STEMI patients with rapid plaque progression: An optical coherence tomography study.
    Int J Cardiol. 2024;400:131821.
    >> Share

  25. KOTOKU N, Ninomiya K, Masuda S, Tsai TY, et al
    Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials.
    Int J Cardiol. 2024;400:131805.
    >> Share

  26. ORTEGA-PAZ L, Bonaca M, Angiolillo DJ
    Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies.
    Int J Cardiol. 2024;400:131803.
    >> Share

  27. LIU Y, Cheng X, Qi B, Wang Y, et al
    Aucubin protects against myocardial ischemia-reperfusion injury by regulating STAT3/NF-kappaB/HMGB-1 pathway.
    Int J Cardiol. 2024;400:131800.
    >> Share

  28. ABDELAZIZ A, Elsayed H, Atta K, Mechi A, et al
    A comprehensive guide on the optimal timing of PCI in the setting of acute coronary syndrome: An updated meta-analysis.
    Int J Cardiol. 2024;400:131774.
    >> Share

  29. YANG C, Sui YG, Shen JY, Guan CD, et al
    Diagnostic performance of ultrasonic flow ratio versus quantitative flow ratio for assessment of coronary stenosis.
    Int J Cardiol. 2024;400:131765.
    >> Share

  30. XIA B, Ding J, Li Q, Zheng K, et al
    Reply to "Loganin: A potential pharmacological agent for myocardial ischemia-reperfusion injury".
    Int J Cardiol. 2024;400:131760.
    >> Share

  31. IANNACCONE M, Franchin L
    Reply to: Supported PCI reduced one-year all-cause mortality compared to standard PCI?
    Int J Cardiol. 2024;400:131707.
    >> Share

    March 2024
  32. CHENG Y, Zhang Q
    Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
    >> Share

  33. PINGITORE A, Zhang C, Vassalle C, Ferragina P, et al
    Machine learning to identify a composite indicator to predict cardiac death in ischemic heart disease.
    Int J Cardiol. 2024 Mar 23:131981. doi: 10.1016/j.ijcard.2024.131981.
    >> Share

  34. ANTONOPOULOS AS, Simantiris S, Tousoulis D
    Thrombus aspiration in STEMI: Whom we aspire it may help?
    Int J Cardiol. 2024;399:131671.
    >> Share

  35. YIFAN D, Yue M, Yubin Z, Jiapei G, et al
    The impact of early in-hospital use of PCSK9 inhibitors on cardiovascular outcomes in acute coronary syndrome patients: A systematic review and meta-analysis.
    Int J Cardiol. 2024;399:131775.
    >> Share

  36. CHAD T, Koulouroudias M, Layton GR, Fashina O, et al
    Frailty in acute coronary syndromes. A systematic review and narrative synthesis of frailty assessment tools and interventions from randomised controlled trials.
    Int J Cardiol. 2024;399:131764.
    >> Share

  37. VANDENBRIELE C, M'Pembele R, Dannenberg L, Metzen D, et al
    Heparin dosing in patients with Impella-supported cardiogenic shock.
    Int J Cardiol. 2024;399:131690.
    >> Share

  38. ZHENG Y, Wang L, Zhao Y, Gong H, et al
    Upregulation of SLAMF8 aggravates ischemia/reperfusion-induced ferroptosis and injury in cardiomyocyte.
    Int J Cardiol. 2024;399:131688.
    >> Share

  39. HUANG M, Chen W, Liu D, Zheng M, et al
    Impact of post-dilatation on post-procedural physiology, microcirculatory resistance, and target vessel failure in STEMI patients undergoing PPCI: A single-center experience.
    Int J Cardiol. 2024;399:131685.
    >> Share

  40. NAKAO S, Ishihara T, Tsujimura T, Hata Y, et al
    Two-year real world clinical outcomes after intravascular imaging device guided percutaneous coronary intervention with ultrathin-strut biodegradable-polymer sirolimus-eluting stent.
    Int J Cardiol. 2024;399:131686.
    >> Share

  41. SKALIDIS I, Noirclerc N, Meier D, Luangphiphat W, et al
    Head-to-head comparison of two angiography-derived fractional flow reserve techniques in patients with high-risk acute coronary syndrome: A multicenter prospective study.
    Int J Cardiol. 2024;399:131663.
    >> Share

  42. NELLES G, Abdelwahed YS, Seppelt C, Meteva D, et al
    Cholesterol crystals at the culprit lesion in patients with acute coronary syndrome are associated with worse cardiovascular outcomes at two years follow up - results from the translational OPTICO-ACS study program.
    Int J Cardiol. 2024;399:131665.
    >> Share

  43. CANDREVA A, Gallo D, Munhoz D, Rizzini ML, et al
    Influence of intracoronary hemodynamic forces on atherosclerotic plaque phenotypes.
    Int J Cardiol. 2024;399:131668.
    >> Share

  44. MCCORD J
    Identification and definition of type 2 myocardial infarction: Where do we go from here?
    Int J Cardiol. 2024 Mar 7:131941. doi: 10.1016/j.ijcard.2024.131941.
    >> Share

  45. GIACOBBE F, Giannino G, Annone U, Morena A, et al
    Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.
    Int J Cardiol. 2024 Mar 2:131933. doi: 10.1016/j.ijcard.2024.131933.
    >> Share

  46. LI Q, Zhao L, Wang C, Liu Z, et al
    Loganin: A potential pharmacological agent for myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2024;398:131650.
    >> Share

  47. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    >> Share

    February 2024
  48. POVLSEN AL, Helgestad OKL, Josiassen J, Christensen S, et al
    Invasive mechanical ventilation in cardiogenic shock complicating acute myocardial infarction: A contemporary Danish cohort analysis.
    Int J Cardiol. 2024 Feb 27:131910. doi: 10.1016/j.ijcard.2024.131910.
    >> Share

  49. KAVSAK PA, Worster A
    The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
    Int J Cardiol. 2024 Feb 20:131898. doi: 10.1016/j.ijcard.2024.131898.
    >> Share

  50. GONZALEZ-URBISTONDO F, Alperi A
    muQFR in ASET Pilot Studies: More Assets in the decision-making process for stable ischemic heart disease.
    Int J Cardiol. 2024 Feb 17:131880. doi: 10.1016/j.ijcard.2024.131880.
    >> Share

  51. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    >> Share

  52. KASSEM M, Ayala PL, Andric-Cancarevic T, Tajsic M, et al
    Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
    Int J Cardiol. 2024 Feb 16:131879. doi: 10.1016/j.ijcard.2024.131879.
    >> Share

  53. XIAO Y, Liu C
    Supported PCI reduced one-year all-cause mortality compared to standard PCI?
    Int J Cardiol. 2024;397:131680.
    >> Share

  54. FERLINI M, Munafo A, Varbella F, Delnevo F, et al
    Achievement of target LDL-cholesterol level in patients with acute coronary syndrome undergoing percutaneous coronary intervention: The JET-LDL registry.
    Int J Cardiol. 2024;397:131659.
    >> Share

  55. DERIMAY F, Aminian A, Lattuca B, Souteyrand G, et al
    One year results of coronary bifurcation revascularization with the re-POT provisional sequential technique. The CABRIOLET registry.
    Int J Cardiol. 2024;397:131632.
    >> Share

  56. GARCIA-GUIMARAES M, Fernandez-Rodriguez D
    Spontaneous coronary artery dissection: A look back to build momentum.
    Int J Cardiol. 2024;397:131557.
    >> Share

  57. PICA S, Crimi G, Castelvecchio S, Pazzanese V, et al
    Corrigendum to "Cardiac magnetic resonance predictors of left ventricular remodelling following acute ST elevation myocardial infarction: The VavirimS study, Pica, Silvia et al." [International Journal of Cardiology, Volume 370, 8-17].
    Int J Cardiol. 2024 Feb 3:131824. doi: 10.1016/j.ijcard.2024.131824.
    >> Share

  58. BOERHOUT CKM, Vink CEM, Lee JM, de Waard GA, et al
    Impact of sex on the assessment of the microvascular resistance reserve.
    Int J Cardiol. 2024 Feb 3:131832. doi: 10.1016/j.ijcard.2024.131832.
    >> Share

  59. IANNACCONE M, Barbero U, Franchin L, Montabone A, et al
    Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlle
    Int J Cardiol. 2024;396:131428.
    >> Share

  60. PIERI M, D'Andria Ursoleo J, Nardelli P, Ortalda A, et al
    Temporary mechanical circulatory support with Impella in cardiac surgery: A systematic review.
    Int J Cardiol. 2024;396:131418.
    >> Share

  61. RONG J, Gu N, Tian H, Shen Y, et al
    Association of the monocytes to high-density lipoprotein cholesterol ratio with in-stent neoatherosclerosis and plaque vulnerability: An optical coherence tomography study.
    Int J Cardiol. 2024;396:131417.
    >> Share

    January 2024
  62. FISZER R, Galeczka M, Smolka G, Sukiennik A, et al
    Multicentre short- and medium-term report on the device closure of a post-myocardial infarction ventricular septal rupture - In search of risk factors for early mortality.
    Int J Cardiol. 2024 Jan 31:131820. doi: 10.1016/j.ijcard.2024.131820.
    >> Share

  63. ANDERSEN PJ, Attar R, Jensen SE, Eftekhari A, et al
    Temporal trends in characteristics and outcomes after myocardial infarction in patients with and without peripheral artery disease - A Nationwide, register-based follow-up study.
    Int J Cardiol. 2024 Jan 25:131812. doi: 10.1016/j.ijcard.2024.131812.
    >> Share

  64. YILDIRIM M, Salbach C, Reich C, Milles BR, et al
    Comparison of the clinical chemistry score to other biomarker algorithms for rapid rule-out of acute myocardial infarction and risk stratification in patients with suspected acute coronary syndrome.
    Int J Cardiol. 2024 Jan 24:131815. doi: 10.1016/j.ijcard.2024.131815.
    >> Share

  65. XU L, Chen Y, Chen S, Wang G, et al
    Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
    Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
    >> Share

  66. NAGARAJA V, Lewis BR, Singh M
    Ten-year outcomes post percutaneous coronary intervention in cardiac transplant recipients.
    Int J Cardiol. 2024 Jan 24:131814. doi: 10.1016/j.ijcard.2024.131814.
    >> Share

  67. UKITA K, Egami Y, Nohara H, Kawanami S, et al
    Predictors of 30-day survival after emergent percutaneous coronary intervention following ventricular Tachyarrhythmias complicating acute myocardial infarction.
    Int J Cardiol. 2024 Jan 21:131806. doi: 10.1016/j.ijcard.2024.131806.
    >> Share

  68. SHALABY G, Sabri S, Alsilami ANS, Alhassani RY, et al
    Predictors of prolonged hospital stay and in-hospital mortality in female patients with acute myocardial infarction with specific reference to diabetes.
    Int J Cardiol. 2024 Jan 17:131785. doi: 10.1016/j.ijcard.2024.131785.
    >> Share

  69. HAO P, Feng S, Suo M, Wang S, et al
    Platelet to albumin ratio: A risk factor related to prognosis in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
    Int J Cardiol. 2024;395:131588.
    >> Share

  70. CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
    Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
    Int J Cardiol. 2024;395:131578.
    >> Share

  71. HO AFW, Yau CE, Ho JS, Lim SH, et al
    Predictors of major adverse cardiac events among patients with chest pain and low HEART score in the emergency department.
    Int J Cardiol. 2024;395:131573.
    >> Share

  72. ELBADAWI A, Elgendy IY
    Revascularization strategies for non-culprit stenosis after acute coronary syndromes: The story so far.
    Int J Cardiol. 2024;395:131564.
    >> Share

  73. XIA B, Ding J, Li Q, Zheng K, et al
    Loganin protects against myocardial ischemia-reperfusion injury by modulating oxidative stress and cellular apoptosis via activation of JAK2/STAT3 signaling.
    Int J Cardiol. 2024;395:131426.
    >> Share

  74. GOLINO M, Morello M, Marazzato J, Blasi F, et al
    Sex-related differences in non-ischemic myocardial injury in the emergency department: A real-world perspective.
    Int J Cardiol. 2024;395:131394.
    >> Share

  75. SAKAI A, Nagao M, Yamamoto A, Nakao R, et al
    (13)N-ammonia positron emission tomography for diagnosis and monitoring of ischemia without obstructive coronary artery disease.
    Int J Cardiol. 2024;395:131392.
    >> Share

  76. TIMOTEO AT, Branco LM, Galrinho A, Rio P, et al
    Global left ventricular myocardial work index and medium-term adverse cardiovascular events after ST-elevation myocardial infarction.
    Int J Cardiol. 2024 Jan 12:131781. doi: 10.1016/j.ijcard.2024.131781.
    >> Share

  77. ZHENG L, Zhu Y, Ma Y, Zhang H, et al
    Relationship between hyperuricemia and the risk of cardiovascular events and chronic kidney disease in both the general population and hypertensive patients: A systematic review and meta-analysis.
    Int J Cardiol. 2024 Jan 11:131779. doi: 10.1016/j.ijcard.2024.131779.
    >> Share

  78. DREGOESC MI, Tigu AB, Bekkering S, van der Heijden CDCC, et al
    Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease.
    Int J Cardiol. 2024 Jan 11:131780. doi: 10.1016/j.ijcard.2024.131780.
    >> Share

  79. DUSE DA, Kelm M, Erkens R
    Lactate load in acute myocardial infarction: Old but gold?
    Int J Cardiol. 2024 Jan 9:131771. doi: 10.1016/j.ijcard.2024.131771.
    >> Share

  80. BERNHARD B, Heydari B, Abdullah S, Francis SA, et al
    Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial.
    Int J Cardiol. 2024 Jan 4:131698. doi: 10.1016/j.ijcard.2023.131698.
    >> Share

  81. FABRIS E, Boldrin C, Gregorio C, Pezzato A, et al
    The Prognostic impact of treatments evolution in STEMI.
    Int J Cardiol. 2024;394:131352.
    >> Share

  82. FEZZI S, Pighi M, Del Sole PA, Scarsini R, et al
    Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques.
    Int J Cardiol. 2024;394:131341.
    >> Share

    December 2023
  83. WU Y, Huang N, Sun T, Zhang B, et al
    Association between normalized lactate load and in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2023 Dec 23:131658. doi: 10.1016/j.ijcard.2023.131658.
    >> Share

  84. LAMBRAKIS K, Khan E, van den Merkhof A, Papendick C, et al
    Impacts of high sensitivity troponin T reporting on care and outcomes in clinical practice: Interactions between low troponin concentrations and participant sex within two randomized clinical trials.
    Int J Cardiol. 2023;393:131396.
    >> Share

  85. LIM J, King J, Williams T, Boyle A, et al
    Unchanged cellular inflammatory response following recurrent ST-elevation myocardial infarction.
    Int J Cardiol. 2023 Dec 15:131656. doi: 10.1016/j.ijcard.2023.131656.
    >> Share

  86. MIRNA M
    Reply to: "The beneficial effects of beta-blocker in patients with myocardial infarction: What are the underlying mechanisms?".
    Int J Cardiol. 2023 Dec 10:131646. doi: 10.1016/j.ijcard.2023.131646.
    >> Share

  87. ELIA E, Bruno F, Crimi G, Wanha W, et al
    Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
    Int J Cardiol. 2023 Dec 5:131622. doi: 10.1016/j.ijcard.2023.131622.
    >> Share

  88. PELLICCIA F, Romiti S, Spunticchia F, Minati A, et al
    Educational tools may turn into decision-making strategies in clinical practice - The case of primary percutaneous coronary intervention risk scores.
    Int J Cardiol. 2023;392:131282.
    >> Share

    November 2023
  89. YARLIOGLUES M, Karacali K, Ilhan BC, Oner DY, et al
    A retrospective study: Associationof C-reactive protein and uric acid to albumin ratio with the no-reflow phenomenonin patients with ST elevation myocardial infarction.
    Int J Cardiol. 2023 Nov 28:131621. doi: 10.1016/j.ijcard.2023.131621.
    >> Share

  90. MORONI F, Corna G, Del Buono MG, Golino M, et al
    Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 Nov 26:131610. doi: 10.1016/j.ijcard.2023.131610.
    >> Share

  91. PENG N, Guo L, Wei Z, Wang X, et al
    Platelet mitochondrial DNA methylation: A novel biomarker for myocardial infarction - A preliminary study.
    Int J Cardiol. 2023 Nov 21:131606. doi: 10.1016/j.ijcard.2023.131606.
    >> Share

  92. LIVORI AC, Ademi Z, Ilomaki J, Pol D, et al
    No effect of remoteness on clinical outcomes following myocardial infarction: An analysis of 43,729 myocardial infarctions in Victoria, Australia.
    Int J Cardiol. 2023 Nov 16:131593. doi: 10.1016/j.ijcard.2023.131593.
    >> Share

  93. BIANCHINI E, Lombardi M, Buonpane A, Ricchiuto A, et al
    Impact of thrombus aspiration on left ventricular remodeling and function in patients with ST-segment elevation myocardial infarction: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2023 Nov 16:131590. doi: 10.1016/j.ijcard.2023.131590.
    >> Share

  94. LI ZH, Zhong WF, Qiu CS, Yang P, et al
    Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
    Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
    >> Share

  95. LINDOW T, Mokhtari A, Nystrom A, Koul S, et al
    Comparison of diagnostic accuracy of current left bundle branch block and ventricular pacing ECG criteria for detection of occlusion myocardial infarction.
    Int J Cardiol. 2023 Nov 4:131569. doi: 10.1016/j.ijcard.2023.131569.
    >> Share

  96. DAI C, Yang Z, Liu M, Zhou Y, et al
    Prognostic value and clinical usefulness of PIANO score in patients undergoing primary percutaneous coronary intervention.
    Int J Cardiol. 2023;390:131258.
    >> Share

  97. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Impact of calcium on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention.
    Int J Cardiol. 2023;390:131254.
    >> Share

  98. NISHIJIMA S, Nagao M, Yamamoto A, Ichihara Y, et al
    Coronary artery bypass grafting transiently improves myocardial flow reserve in patients with impaired left ventricular function.
    Int J Cardiol. 2023;390:131231.
    >> Share

  99. ZHU Y, Wang Y, Liu X, Wang Y, et al
    Genetically predicted osteoprotegerin levels and the risk of cardiovascular diseases: A Mendelian randomization study.
    Int J Cardiol. 2023;390:131233.
    >> Share

  100. MASIERO G, Tarantini G
    Sex and cardiogenic shock: Still no time for answers but for evidences.
    Int J Cardiol. 2023;390:131224.
    >> Share

  101. LUO X, Liu M, Wang S, Chen Y, et al
    Combining metabolomics and OCT to reveal plasma metabolic profiling and biomarkers of plaque erosion and plaque rupture in STEMI patients.
    Int J Cardiol. 2023;390:131223.
    >> Share

    October 2023
  102. BREEN TJ, Raphael CE, Ingraham B, Lane C, et al
    Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
    Int J Cardiol. 2023 Oct 30:131565. doi: 10.1016/j.ijcard.2023.131565.
    >> Share

  103. BICCIRE FG, Lip GYH, Pastori D
    Reply to: The C2HEST and mC2HEST scores to predict the risk of new onset atrial fibrillation after presentation with acute coronary syndrome.
    Int J Cardiol. 2023 Oct 21:131547. doi: 10.1016/j.ijcard.2023.131547.
    >> Share

  104. LI Y, Yao S, Chen X
    The beneficial effects of beta-blocker in patients with myocardial infarction: What are the underlying mechanisms?
    Int J Cardiol. 2023 Oct 20:131544. doi: 10.1016/j.ijcard.2023.131544.
    >> Share

  105. CLAUDIA STOLLBERGER MD, Finsterer J
    More data on the association of Takotsubo syndrome and stroke are warranted.
    Int J Cardiol. 2023 Oct 20:131548. doi: 10.1016/j.ijcard.2023.131548.
    >> Share

  106. AVANZAS P, de la Torre JM
    Seeking precision in percutaneous coronary revascularization: The best stent for each setting.
    Int J Cardiol. 2023;389:131222.
    >> Share

  107. DE MICHIELI L, De Gaspari M, Sinigiani G, Lupi A, et al
    Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance.
    Int J Cardiol. 2023;389:131204.
    >> Share

  108. ZHANG S, Yang L, Guo S, Hu F, et al
    Mannose binding lectin-associated serine protease-1 is a novel contributor to myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2023;389:131193.
    >> Share

  109. CORTES C, Fernandez-Corredoira PM, Liu L, Lopez-Palop R, et al
    Long-term prognostic value of quantitative-flow-ratio-concordant revascularization in stable coronary artery disease.
    Int J Cardiol. 2023;389:131176.
    >> Share

  110. LYONS KS, Herity N, Lee G, Talbot C, et al
    Assay interference as a cause of false positive troponin T elevation in emergency department patients.
    Int J Cardiol. 2023;389:131165.
    >> Share

  111. JAIN SS, Yu J, Arnott C, Neal B, et al
    Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial.
    Int J Cardiol. 2023 Oct 14:131444. doi: 10.1016/j.ijcard.2023.131444.
    >> Share

  112. WANG C, Zhang M, Yan J, Wang R, et al
    Erratum to "Chemokine-like receptor 1 deficiency impedes macrophage phenotypic transformation and cardiac repair after myocardial infarction" [International Journal of Cardiology 372C (2023) 6-14].
    Int J Cardiol. 2023 Oct 10:131338. doi: 10.1016/j.ijcard.2023.131338.
    >> Share

  113. WURDINGER M, Schweiger V, Gilhofer T, Cammann VL, et al
    Twenty-five-year trends in incidence, angiographic appearance, and management of spontaneous coronary artery dissection.
    Int J Cardiol. 2023 Oct 10:131429. doi: 10.1016/j.ijcard.2023.131429.
    >> Share

  114. ROONGSANGMANOON W, Wongsoasup A, Chichareon P, Suwannasom P, et al
    Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Int J Cardiol. 2023;388:131167.
    >> Share

  115. AHN JH, Kim MC, Ahn Y, Cho DI, et al
    Culprit lesion plaque characteristics and angiopoietin like 4 in acute coronary syndrome: A virtual histology-intravascular ultrasound analysis.
    Int J Cardiol. 2023;388:131164.
    >> Share

  116. CORNELISSEN A, Florescu RA, Reese S, Behr M, et al
    In-vivo assessment of vascular injury for the prediction of in-stent restenosis.
    Int J Cardiol. 2023;388:131151.
    >> Share

  117. LECHNER I, Reindl M, Metzler B, Reinstadler SJ, et al
    Embracing nomograms: A leap in the dark for enhanced risk stratification in STEMI.
    Int J Cardiol. 2023;388:131106.
    >> Share

    September 2023
  118. EMMERT-FEES KMF, Luhar S, O'Flaherty M, Kypridemos C, et al
    Forecasting the mortality burden of coronary heart disease and stroke in Germany: National trends and regional inequalities.
    Int J Cardiol. 2023 Sep 25:131359. doi: 10.1016/j.ijcard.2023.131359.
    >> Share

  119. YAMAMOTO T, Kawamori H, Toba T, Kakizaki S, et al
    Clinical impact of optical coherence tomography findings after drug-coated balloon treatment for patients with acute coronary syndromes.
    Int J Cardiol. 2023;387:131149.
    >> Share

  120. CHONG TK, Chen J, Lyu L, Wei Y, et al
    Clinical characteristics and outcome correlates of Chinese patients with takotsubo syndrome: Results from the first Chinese takotsubo syndrome registry.
    Int J Cardiol. 2023;387:131129.
    >> Share

  121. MITSUTAKE Y, Ishii J, Fukumoto Y, Ito S, et al
    Differential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery disease.
    Int J Cardiol. 2023;387:131138.
    >> Share

  122. ROZADO J, Avanzas P
    Complete revascularization in STEMI and multivessel coronary artery disease: In search of the best strategy.
    Int J Cardiol. 2023;387:131124.
    >> Share

  123. WU H, Xiao Z
    A knowledge graph-based analytical model for mining clinical value of drug stress echocardiography for diagnosis, risk stratification and prognostic evaluation of coronary artery disease.
    Int J Cardiol. 2023;387:131107.
    >> Share

  124. SHARIFOV OF, Denney TS Jr, Girard AA, Gupta H, et al
    Coronary artery disease is associated with impaired atrial function regardless of left ventricular filling pressure.
    Int J Cardiol. 2023;387:131102.
    >> Share

  125. XU C, Meng J, He J
    History of peripheral artery disease as a cardiovascular risk predictor of patients with acute coronary syndrome.
    Int J Cardiol. 2023;387:131105.
    >> Share

  126. LUCCI C, Cosentino N, Marenzi G
    Unstable angina: A clinical entity on the verge of extinction?
    Int J Cardiol. 2023 Sep 5:131329. doi: 10.1016/j.ijcard.2023.131329.
    >> Share

  127. FUJII T, Kasai S, Kawamura Y, Yoshimachi F, et al
    Temporal variations in ischemic and bleeding event risks after acute coronary syndrome during dual antiplatelet therapy.
    Int J Cardiol. 2023 Sep 5:131340. doi: 10.1016/j.ijcard.2023.131340.
    >> Share

  128. VOGEL B, Tycinska A, Sambola A
    Cardiogenic shock in women - A review and call to action.
    Int J Cardiol. 2023;386:98-103.
    >> Share

  129. WANG H, Tucker WJ, Jonnagaddala J, Schutte AE, et al
    Using machine learning to predict cardiovascular risk using self-reported questionnaires: Findings from the 45 and Up Study.
    Int J Cardiol. 2023;386:149-156.
    >> Share

  130. LIEDER HR, Adam V, Skyschally A, Sturek M, et al
    Attenuation of ST-segment elevation by ischemic preconditioning: Reflection of cardioprotection in Gottingen but not in Ossabaw minipigs.
    Int J Cardiol. 2023;386:109-117.
    >> Share

  131. ANGIOLILLO DJ, Erlinge D, Ferreiro JL, Gale CP, et al
    European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey.
    Int J Cardiol. 2023;386:8-16.
    >> Share

  132. CANDREVA A, Lodi Rizzini M, Schweiger V, Gallo D, et al
    Is spontaneous coronary artery dissection (SCAD) related to local anatomy and hemodynamics? An exploratory study.
    Int J Cardiol. 2023;386:1-7.
    >> Share

  133. TANG LH, Doherty P, Skou ST, Harrison A, et al
    Optimal outcomes from cardiac rehabilitation are associated with longer-term follow-up and risk factor status at 12 months: An observational registry-based study.
    Int J Cardiol. 2023;386:134-140.
    >> Share

  134. OOMENS T, Vos NS, van der Schaaf RJ, Amoroso G, et al
    EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries.
    Int J Cardiol. 2023;386:24-29.
    >> Share

    August 2023
  135. BICCIRE FG, Lip GYH, Pastori D
    Reply to: Prediction scores for new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Two sides of the same coin.
    Int J Cardiol. 2023 Aug 31:131305. doi: 10.1016/j.ijcard.2023.131305.
    >> Share

  136. TROMBARA F, Cosentino N, Marenzi G
    Intracranial haemorrhage in acute myocardial infarction: A rare but dramatic complication.
    Int J Cardiol. 2023 Aug 30:131300. doi: 10.1016/j.ijcard.2023.131300.
    >> Share

  137. LI F, Peng J, Lu Y, Zhou M, et al
    Blockade of CXCR4 promotes macrophage autophagy through the PI3K/AKT/mTOR pathway to alleviate coronary heart disease.
    Int J Cardiol. 2023 Aug 29:131303. doi: 10.1016/j.ijcard.2023.131303.
    >> Share

  138. WAN P, Xu W, Jiang Q
    The C2HEST and mC2HEST scores to predict the risk of new onset atrial fibrillation after presentation with acute coronary syndrome.
    Int J Cardiol. 2023 Aug 25:131280. doi: 10.1016/j.ijcard.2023.131280.
    >> Share

  139. EFTEKHARI A, van de Hoef TP, Hoshino M, Lee JM, et al
    Changes in microvascular resistance following percutaneous coronary intervention - From the ILIAS global registry.
    Int J Cardiol. 2023 Aug 25:131296. doi: 10.1016/j.ijcard.2023.131296.
    >> Share

  140. KUMAR R, Shaikh AH, Kumar A, Solangi BA, et al
    Age and gender-based categorization of very premature, premature, and non-premature acute myocardial infarction: A comparison of clinical and angiographic profile and in-hospital outcomes.
    Int J Cardiol. 2023 Aug 23:131292. doi: 10.1016/j.ijcard.2023.131292.
    >> Share

  141. JESSEN N, Andersen JA, Tayal B, Ostergaard L, et al
    Takotsubo syndrome and stroke risk: A nationwide register-based study.
    Int J Cardiol. 2023 Aug 22:131283. doi: 10.1016/j.ijcard.2023.131283.
    >> Share

  142. CHOI BG, Park JY, Rha SW, Noh YK, et al
    Pre-test probability for coronary artery disease in patients with chest pain based on machine learning techniques.
    Int J Cardiol. 2023;385:85-93.
    >> Share

  143. GURGOGLIONE FL, Rizzello D, Giacalone R, Ferretti M, et al
    Precipitating factors in patients with spontaneous coronary artery dissection: Clinical, laboratoristic and prognostic implications.
    Int J Cardiol. 2023;385:1-7.
    >> Share

  144. DAVIES A, Wenzl FA, Li XS, Winzap P, et al
    Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes.
    Int J Cardiol. 2023 Aug 11:131261. doi: 10.1016/j.ijcard.2023.131261.
    >> Share

  145. YAN T, Li X, Wang X, Zhang Y, et al
    Rhodiola wallichiana var.cholaensis protects against myocardial ischemia-reperfusion injury by attenuating oxidative stress-mediated apoptosis via enhancing Nrf2 signaling.
    Int J Cardiol. 2023;384:62-73.
    >> Share

  146. IANNACCONE M, Bertaina M, Morici N, Chieffo A, et al
    Impact of sex in cardiogenic shock outcomes: Still not seeing it coming?
    Int J Cardiol. 2023;384:50-51.
    >> Share

  147. PAVSIC N, Zbacnik R, Berden P, Kacar P, et al
    The association between myocardial ischemia and myocardial dysfunction in adult patients with systemic right ventricle - A single centre multimodality study.
    Int J Cardiol. 2023;384:31-36.
    >> Share

  148. JIANG Y, Zhao Y, Li ZY, Chen S, et al
    Potential roles of microRNAs and long noncoding RNAs as diagnostic, prognostic and therapeutic biomarkers in coronary artery disease.
    Int J Cardiol. 2023;384:90-99.
    >> Share

    July 2023
  149. DAKSHI A, Salmon T, Collinson P, Ihsan J, et al
    Unstable angina in the context of high-sensitive troponins: Still a marker of high risk? A comparison of outcomes with adjudicated type 1 myocardial infarction.
    Int J Cardiol. 2023 Jul 29:131226. doi: 10.1016/j.ijcard.2023.131226.
    >> Share

  150. DE KONING MLY, Al Ali L, Bourgonje AR, Assa S, et al
    Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jul 28:131214. doi: 10.1016/j.ijcard.2023.131214.
    >> Share

  151. XIAO X
    Prediction scores for new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Two sides of the same coin.
    Int J Cardiol. 2023 Jul 28:131221. doi: 10.1016/j.ijcard.2023.131221.
    >> Share

  152. ZHANG P, Pang S, Du L, Li J, et al
    Clinical characteristics and outcomes of patients with intracerebral hemorrhage after acute myocardial infarction.
    Int J Cardiol. 2023 Jul 25:131218. doi: 10.1016/j.ijcard.2023.131218.
    >> Share

  153. ASSAF A, van der Graaf M, van Boven N, van Ettinger MJB, et al
    Effect of myocardial scar size on the risk of ventricular arrhythmias in patients with chronic Total coronary occlusion.
    Int J Cardiol. 2023 Jul 21:131205. doi: 10.1016/j.ijcard.2023.131205.
    >> Share

  154. JONG CB, Lu TS, Chen TY, Chen CK, et al
    Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome.
    Int J Cardiol. 2023 Jul 18:131195. doi: 10.1016/j.ijcard.2023.131195.
    >> Share

  155. DE ANGELIS E, Bochaton T, Ammirati E, Tedeschi A, et al
    Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes.
    Int J Cardiol. 2023;383:82-88.
    >> Share

  156. ANAND VV, Zhe ELC, Chin YH, Goh RSJ, et al
    Socioeconomic deprivation and prognostic outcomes in acute coronary syndrome: A meta-analysis using multidimensional socioeconomic status indices.
    Int J Cardiol. 2023;383:140-150.
    >> Share

  157. POMPEI G, Campo G, Ruggiero R, Maffeo D, et al
    Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study.
    Int J Cardiol. 2023;383:1-7.
    >> Share

  158. LOPEZ-PALOP R, Carrillo P, Leithold G, Lozano I, et al
    Accuracy of the angiography-based quantitative flow ratio in intermediate left main coronary artery lesions and comparison with visual estimation.
    Int J Cardiol. 2023;383:8-14.
    >> Share

  159. SPIRITO A, Valgimigli M, Cao D, Baber U, et al
    Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
    Int J Cardiol. 2023;383:24-32.
    >> Share

  160. CASTALDI G, Bharadwaj AS, Bagur R, Van Spall HGC, et al
    Prevalence and outcomes of type 2 myocardial infarction in patients with cancer: A retrospective analysis from the National Inpatient Sample dataset.
    Int J Cardiol. 2023 Jul 11:131154. doi: 10.1016/j.ijcard.2023.131154.
    >> Share

  161. SAITO T, Fujisaki T, Aikawa T, Kampaktsis PN, et al
    Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis.
    Int J Cardiol. 2023 Jul 9:131157. doi: 10.1016/j.ijcard.2023.131157.
    >> Share

  162. MIRNA M, Berezin A, Schmutzler L, Demirel O, et al
    Early beta-blocker therapy improves in-hospital mortality of patients with non-ST-segment elevation myocardial infarction - a meta-analysis.
    Int J Cardiol. 2023 Jul 7:131160. doi: 10.1016/j.ijcard.2023.131160.
    >> Share

  163. LIAO J, Zhang M, Xu R, Wu R, et al
    Soluble interleukin-2 receptor predicts acute kidney injury and in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2023 Jul 7:131156. doi: 10.1016/j.ijcard.2023.131156.
    >> Share

  164. MILLET LM, Ali MJ, Mohandas R
    Practice patterns and clinical outcomes of severe coronary artery disease in dialysis patients.
    Int J Cardiol. 2023;382:1-2.
    >> Share

    June 2023
  165. CARVALHO A, Ji Z, Zhang R, Zuo W, et al
    Inhibition of miR-195-3p protects against cardiac dysfunction and fibrosis after myocardial infarction.
    Int J Cardiol. 2023 Jun 23:131128. doi: 10.1016/j.ijcard.2023.131128.
    >> Share

  166. SCHMITT A, Schupp T, Rusnak J, Ruka M, et al
    Does sex affect the risk of 30-day all-cause mortality in cardiogenic shock?
    Int J Cardiol. 2023;381:105-111.
    >> Share

  167. FUJII T
    Replay to "duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk".
    Int J Cardiol. 2023;381:1.
    >> Share

  168. ZHANG L, Li Y, Li H, Wang R, et al
    Association between admission heart rate and major adverse cardiovascular events in acute myocardial infarction participants with different left ventricular ejection fraction.
    Int J Cardiol. 2023 Jun 15:131122. doi: 10.1016/j.ijcard.2023.131122.
    >> Share

  169. PARCO C, Trostler J, Brockmeyer M, Hoss A, et al
    Risk-adjusted management in catheterization procedures for non-ST-segment elevation myocardial infarction: A standard operating procedure pilot study.
    Int J Cardiol. 2023 Jun 9:S0167-5273(23)00836.
    >> Share

  170. MAKUVIRE TT, Latif Z, Kumar P, Samad Z, et al
    Trends in ischemic heart disease among females in low-and middle-income countries from 1990 to 2019.
    Int J Cardiol. 2023 Jun 7:S0167-5273(23)00838.
    >> Share

  171. ROMAGNOLI E, Burzotta F, Cerracchio E, Russo G, et al
    Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.
    Int J Cardiol. 2023 Jun 6:S0167-5273(23)00742.
    >> Share

  172. GUREVITZ C, Assali A, Mohsan J, Gmach SF, et al
    The obesity paradox in patients with acute coronary syndromes over 2 decades - the ACSIS registry 2000-2018.
    Int J Cardiol. 2023;380:48-55.
    >> Share

  173. LOPEZ-PALOP R, Carrillo P, Lozano I
    Non-hyperemic, non pressure wire, coronary physiology. A further step towards the generalization of physiology in the cath-lab?
    Int J Cardiol. 2023;380:1-3.
    >> Share

    May 2023
  174. BICCIRE FG, Tanzilli G, Prati F, Sammartini E, et al
    Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry.
    Int J Cardiol. 2023 May 16:S0167-5273(23)00715.
    >> Share

  175. KLUGER N
    A case of misdiagnosed vasospastic angina in the last of us?
    Int J Cardiol. 2023;379:15.
    >> Share

  176. CROOIJMANS C, Jansen TPJ, Konst RE, Woudstra J, et al
    Design and rationale of the NetherLands registry of invasive Coronary vasomotor Function Testing (NL-CFT).
    Int J Cardiol. 2023;379:1-8.
    >> Share

  177. ZHAO CX, Wei L, Dong JX, He J, et al
    Nomograms referenced by cardiac magnetic resonance in the prediction of cardiac injuries in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 May 13:S0167-5273(23)00700.
    >> Share

  178. ZUIN M, di Fusco SA, De Caterina R, Roncon L, et al
    Declining trends of premature mortality from ischemic heart disease and regional differences in Italy from 2011 to 2017.
    Int J Cardiol. 2023 May 8:S0167-5273(23)00649.
    >> Share

  179. XIN A, Li K, Qian G, Chen Y, et al
    Reply to Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: Misinterpretation.
    Int J Cardiol. 2023 May 5:S0167-5273(23)00653.
    >> Share

  180. LEE WJ, Cheng H, Whitney BM, Nance RM, et al
    Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00648.
    >> Share

  181. AHMED AI, Al-Mallah MH
    Reply to SPECT and STE: Which one is better in incremental prognostic value over CCTA.
    Int J Cardiol. 2023;378:164-165.
    >> Share

  182. GAUTHIER V, Lafrance M, Barthoulot M, Rousselet L, et al
    Long-term follow-up of survivors of a first acute coronary syndrome: Results from the French MONICA registries from 2009 to 2017.
    Int J Cardiol. 2023;378:138-143.
    >> Share

  183. LANDI A
    Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk.
    Int J Cardiol. 2023;378:10.
    >> Share

  184. KIMURA S
    Reliability of immature neutrophils in the risk stratification of acute coronary syndrome lesions.
    Int J Cardiol. 2023;378:111-112.
    >> Share

  185. HERMANN R, Mestre Cordero VE, Fernandez Pazos MLM, Reznik FJ, et al
    Role of autophagy in simulated ischemic-reperfused left atrial myocardium.
    Int J Cardiol. 2023;378:77-88.
    >> Share

  186. KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
    Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
    Int J Cardiol. 2023;378:105-110.
    >> Share

  187. WANG Z, Yang J, Li C, Huang J, et al
    Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.
    Int J Cardiol. 2023;378:11-19.
    >> Share

  188. VAN DE HOEF TP, Boerhout CKM, Piek JJ
    Reply to: "Do we still need to perform FFR and PCI".
    Int J Cardiol. 2023;378:22.
    >> Share

  189. GRAGNANO F, Montalto C, Oreglia JA, Calabro P, et al
    Physiology-guided revascularization of non-culprit lesions in patients with STEMI: Could vFFR be the way?
    Int J Cardiol. 2023;378:20-21.
    >> Share

  190. VARMA Y, Jena NK, Arsene C, Patel K, et al
    Disparities in the management of non-ST-segment elevation myocardial infarction in the United States.
    Int J Cardiol. 2023 May 1:S0167-5273(23)00592.
    >> Share

    April 2023
  191. BOTTIROLI M, Calini A, Morici N, Tavazzi G, et al
    Acute kidney injury in patients with acute decompensated heart failure-cardiogenic shock: Prevalence, risk factors and outcome.
    Int J Cardiol. 2023 Apr 28:S0167-5273(23)00612.
    >> Share

  192. SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
    Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
    Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
    >> Share

  193. FLYGARE O, Boberg J, Ruck C, Hofmann R, et al
    Association of anxiety or depression with risk of recurrent cardiovascular events and death after myocardial infarction: A nationwide registry study.
    Int J Cardiol. 2023 Apr 18:S0167-5273(23)00576.
    >> Share

  194. MORI R, Macaya F, Giacobbe F, Salinas P, et al
    Clinical and angiographic features of SCAD type 4.
    Int J Cardiol. 2023;377:22-25.
    >> Share

  195. LAKE P, Halbach M, Kardasch M, Mauri V, et al
    Comparison of vessel fractional flow reserve with invasive resting full-cycle ratio in patients with intermediate coronary lesions.
    Int J Cardiol. 2023;377:1-8.
    >> Share

  196. REN L, Han Y, Long M, Yan L, et al
    Association with carotid plaque parameters detected on contrast-enhanced ultrasound and coronary artery plaque progression in non-culprit lesions: A retrospective study.
    Int J Cardiol. 2023;377:115-122.
    >> Share

  197. VAN DE HOEF TP, Stegehuis VE, Madera-Cambero MI, van Royen N, et al
    Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements - DEFINE-FLOW core laboratory sub-study.
    Int J Cardiol. 2023;377:9-16.
    >> Share

  198. ISHII H
    Cardio-renal interaction in coronary artery disease.
    Int J Cardiol. 2023;377:17-18.
    >> Share

  199. ISHII M, Nakamura T, Tsujita K
    Impact of veno-arterial extracorporeal membrane oxygenation on mortality in cardiogenic shock after acute myocardial infarction: Real-world evidence.
    Int J Cardiol. 2023 Apr 13:S0167-5273(23)00521.
    >> Share

  200. NAGATA T, Minami Y, Katsura A, Asakura K, et al
    Optical coherence tomography factors for adverse events in patients with severe coronary calcification.
    Int J Cardiol. 2023;376:28-34.
    >> Share

  201. OSAWA K
    Can carotid plaque assessment perform the role of a risk predictor for secondary prevention?
    Int J Cardiol. 2023;376:154-155.
    >> Share

  202. ZHANG ZH
    Thrombospondin-1, a potential target in acute coronary syndrome.
    Int J Cardiol. 2023;376:27.
    >> Share

  203. CARBONE RG, Puppo F
    Breast arterial calcification and epicardial adipose tissue volume: Emerging risk factors of cardiovascular diseases.
    Int J Cardiol. 2023;376:134.
    >> Share

  204. CARBONE RG, Puppo F
    The role of adrenomedullin in acute coronary syndrome.
    Int J Cardiol. 2023;376:22-23.
    >> Share

  205. TSIREBOLOS G, Tsoporis JN, Drosatos IA, Izhar S, et al
    Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.
    Int J Cardiol. 2023;376:127-133.
    >> Share

  206. TSAI TY, Onuma Y, Serruys PW
    Do we still need to perform FFR and PCI?
    Int J Cardiol. 2023;376:48.
    >> Share

  207. MARTIJN S, Maarten F, Danielle Z, Toshiki K, et al
    Psychosocial predictors for cardiac rehabilitation participation for patients with coronary artery disease.
    Int J Cardiol. 2023;376:18-21.
    >> Share

  208. JAMMOUL N, Mercier G, Roubille F
    Could colchicine reduce cardiovascular events in coronary artery disease without increasing all-cause mortality: Avoid optical illusions!
    Int J Cardiol. 2023;376:125-126.
    >> Share

    March 2023
  209. DENEGRI A, Magnani G, Kraler S, Bruno F, et al
    History of peripheral artery disease and cardiovascular risk of real-word patients with acute coronary syndrome: Role of inflammation and comorbidities.
    Int J Cardiol. 2023 Mar 21:S0167-5273(23)00454.
    >> Share

  210. POZZI M, Payet C, Polazzi S, L'Hospital A, et al
    Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock after acute myocardial infarction: Insights from a French nationwide database.
    Int J Cardiol. 2023 Mar 20:S0167-5273(23)00446.
    >> Share

  211. MA Z, Wang M, Xu X, Zhang Y, et al
    Thrombospondin-1 plasma levels associated with in-hospital major adverse cardiovascular events in patients with acute coronary syndrome.
    Int J Cardiol. 2023;375:98-103.
    >> Share

  212. BELLINO M, Piscione F
    Spontaneous coronary artery dissection: do we need different tailored strategies?
    Int J Cardiol. 2023;375:7-8.
    >> Share

  213. SIMSEK B, Tajti P, Carlino M, Ojeda S, et al
    External validation of the PROGRESS-CTO complication risk scores: Individual patient data pooled analysis of 3 registries.
    Int J Cardiol. 2023;375:14-20.
    >> Share

  214. WANG IC, Lin JH, Lee WS, Liu CH, et al
    Baicalein and luteolin inhibit ischemia/reperfusion-induced ferroptosis in rat cardiomyocytes.
    Int J Cardiol. 2023;375:74-86.
    >> Share

  215. LOPEZ-PALOP R, Lozano I, Carrillo P
    COVID-19 pandemic: National outbreak and acute coronary syndrome. Collateral damages?
    Int J Cardiol. 2023;375:144-146.
    >> Share

  216. BENATTI G, Gragnano F, Vignali L, Calabro P, et al
    Timing and modality of complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00393.
    >> Share

  217. SABOUR S
    Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: Misinterpretation.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00365.
    >> Share

  218. KOOLAJI S, Tehrani YS, Azadnajafabad S, Moghaddam SS, et al
    A 30-year trend of ischemic heart disease burden in a developing country; a systematic analysis of the global burden of disease study 2019 in Iran.
    Int J Cardiol. 2023 Mar 8:S0167-5273(23)00339.
    >> Share

  219. TANAKA S, Okada K, Kitahara H, Luikart H, et al
    Impact of myocardial bridging on coronary artery plaque formation and long-term mortality after heart transplantation.
    Int J Cardiol. 2023 Mar 7:S0167-5273(23)00343.
    >> Share

  220. DAYEM KA, Younis O, Zarif B, Attia S, et al
    Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients - DACAMI (a randomized controlled clinical trial).
    Int J Cardiol. 2023 Mar 6:S0167-5273(23)00329.
    >> Share

  221. PELLICCIA F, Camici PG
    Updates on MINOCA and INOCA through the 2022 publications in the International Journal of Cardiology.
    Int J Cardiol. 2023;374:8-11.
    >> Share

  222. WAN M, Lu Y, Mao B, Yu S, et al
    Immature neutrophil is associated with coronary plaque vulnerability based on optical coherence tomography analysis.
    Int J Cardiol. 2023;374:89-93.
    >> Share

  223. SCHINDLER TH, Bhandiwad AR, Jain S
    Role of cardiac magnetic resonance imaging in the prediction of left ventricular remodeling after infarction: Emerging new concepts?
    Int J Cardiol. 2023;374:127-128.
    >> Share

  224. CILIBERTI G, Verdoia M, Musella F, Ceriello L, et al
    MINOCA in Men and Women: Different Conditions and a Single Destiny?
    Int J Cardiol. 2023;374:6-7.
    >> Share

  225. ROSSELLO X, Blaya-Pena L, Siquier-Padilla J
    The COMBO stent: Real-world patients vs. objective performance criteria.
    Int J Cardiol. 2023;374:33-34.
    >> Share

  226. MAHMOUD HT, Berton G, Cordiano R, Palmieri R, et al
    Microalbuminuria during acute coronary syndrome: Association with 22-year mortality and causes of death. The ABC-8* study on heart disease. (*ABC is an acronym for Adria, Bassano, Conegliano, and Padova Hospitals).
    Int J Cardiol. 2023;374:100-107.
    >> Share

  227. XU J, Fan Y, Zhou R, Shao J, et al
    The interaction of persistent antiphospholipid antibodies positivity and cigarette smoking is associated with an increased risk of cardiovascular events: Cross-sectional and longitudinal analysis.
    Int J Cardiol. 2023;374:108-114.
    >> Share

  228. PINXTERHUIS TH, Ploumen EH, Zocca P, Doggen CJM, et al
    Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.
    Int J Cardiol. 2023;374:27-32.
    >> Share

    February 2023
  229. D'ASCENZO F, Bruno F, Iannaccone M, Testa G, et al
    Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00256.
    >> Share

  230. DHINDSA DS, Desai SR, Jin Q, Sandesara PB, et al
    Circulating progenitor cells and outcomes in patients with coronary artery disease.
    Int J Cardiol. 2023;373:7-16.
    >> Share

  231. WEINTRAUB WS, Mancini GBJ, Boden WE
    Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Int J Cardiol. 2023;373:39-43.
    >> Share

  232. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    >> Share

  233. WAKABAYASHI K, Higuchi S, Miyachi H, Minatsuki S, et al
    Clinical features and predictors of non-cardiac death in patients hospitalised for acute myocardial infarction: Insights from the Tokyo CCU network multicentre registry.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00238.
    >> Share

  234. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    >> Share

  235. LIM J, Davies A, Brienesse S, Mabotuwana NS, et al
    Inflammatory cell response following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention and its impact on cardiovascular outcomes: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Feb 7:S0167-5273(23)00123.
    >> Share

  236. CAMERON JD
    Non-hyperemic pressure-derived indices for guiding coronary intervention: Assessing comparative use and application.
    Int J Cardiol. 2023;372:46-47.
    >> Share

  237. WILLIAMS MGL, Dastidar A, Liang K, Johnson TW, et al
    Sex differences in patients with acute coronary syndromes and non-obstructive coronary arteries: Presentation and outcome.
    Int J Cardiol. 2023;372:15-22.
    >> Share

    January 2023
  238. YOSHII T, Matsuzawa Y, Kato S, Sato R, et al
    Endothelial dysfunction predicts bleeding and cardiovascular death in acute coronary syndrome.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00121.
    >> Share

  239. PINGITORE A
    Editorial on the manuscript "Features of metabolic syndrome and inflammation independently affect left ventricular function early after first myocardial infarction".
    Int J Cardiol. 2023 Jan 19:S0167-5273(23)00059.
    >> Share

  240. XING Y, Qiu Y, Yang L, Yuan Z, et al
    Cost-effectiveness analysis of screening for peripheral artery disease in patients with coronary artery disease in China: A Markov model.
    Int J Cardiol. 2023;371:420-426.
    >> Share

  241. WONG MYZ, Yap JJL, Chih HJ, Yan BPY, et al
    Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration.
    Int J Cardiol. 2023;371:84-91.
    >> Share

  242. NARANG N, Nakamura M, Imamura T
    Disparities in mechanical circulatory support utilization post cardiac arrest: An uncomfortable reality.
    Int J Cardiol. 2023;371:126-127.
    >> Share

  243. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Reply to: Among patients with MINOCA women versus men have the increased risks of MACE and stroke?
    Int J Cardiol. 2023;371:80-81.
    >> Share

  244. PICA S, Di Odoardo L, Testa L, Bollati M, et al
    Collateral presence and extent do not predict myocardial viability and ischemia in chronic total occlusions: A stress-CMR study.
    Int J Cardiol. 2023;371:10-15.
    >> Share

  245. KONG G, Chin YH, Chong B, Goh RSJ, et al
    Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
    Int J Cardiol. 2023;371:432-440.
    >> Share

  246. FEENSTRA RGT, Seitz A, Boerhout CKM, de Winter RJ, et al
    Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index.
    Int J Cardiol. 2023;371:16-20.
    >> Share

  247. HAO T, Jiang Y, Wu C, Li C, et al
    Clinical outcome and risk factors for acute fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation: An analysis of nationwide CSECLS database in China.
    Int J Cardiol. 2023;371:229-235.
    >> Share

  248. WANG L, Maehara A, Zhang X, Lv R, et al
    Quantification of patient-specific coronary material properties and their correlations with plaque morphological characteristics: An in vivo IVUS study.
    Int J Cardiol. 2023;371:21-27.
    >> Share

  249. GULATI M, Khan N, George M, Berry C, et al
    Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international.
    Int J Cardiol. 2023;371:28-39.
    >> Share

  250. DU L, Wang P, Chen H, Zhang Y, et al
    Among patients with MINOCA women versus men have the increased risks of MACE and stroke?
    Int J Cardiol. 2023;371:82.
    >> Share

  251. DZIEWIERZ A
    The time is always right to do what is right: TAVI and timing of PCI.
    Int J Cardiol. 2023;371:128-129.
    >> Share

  252. AHMED AI, Al Rifai M, Alahdab F, Saad JM, et al
    Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study.
    Int J Cardiol. 2023;371:465-471.
    >> Share

  253. GRAGNANO F, Pelliccia F, Cesaro A, Calabro P, et al
    Geographic variations in percutaneous versus surgical coronary revascularization: A global perspective from the SYNTAXES trial.
    Int J Cardiol. 2023;371:132-134.
    >> Share

  254. SCALONE G, Di Vito L, Mariani L, Silenzi S, et al
    Which therapy for MINOCA patients? "Dazed and confused for so long, it is not true".
    Int J Cardiol. 2023;371:78-79.
    >> Share

  255. GILANI A, Maknojia A, Mufty M, Patel S, et al
    Mechanical circulatory device utilization in cardiac arrest: Racial and gender disparities and impact on mortality.
    Int J Cardiol. 2023;371:460-464.
    >> Share

  256. AW A, de Jong MC, Varghese S, Lee J, et al
    A systematic cohort review of pheochromocytoma-induced typical versus atypical Takotsubo cardiomyopathy.
    Int J Cardiol. 2023;371:287-292.
    >> Share

  257. FUJII T, Endo S, Tsuchiya R, Nagamatsu H, et al
    Estimation of adverse events associated with P2Y12 receptor inhibitors stratified by academic research consortium for high bleeding risk criteria in acute coronary syndrome.
    Int J Cardiol. 2023 Jan 14:S0167-5273(23)00061.
    >> Share

  258. LIANG J, Zhang Z
    Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00043.
    >> Share

  259. LIARAKOS AL, Tran P, Keegan M, Robbins T, et al
    Real-world evaluation of glucose-lowering therapies and the use of weight-adjusted variable rate intravenous insulin infusion in the management of hyperglycaemia in patients with acute coronary syndrome (REGULATE-ACS).
    Int J Cardiol. 2023;370:26-34.
    >> Share

  260. BULLUCK H, Mozid AM
    Optimising patient selection for CTO PCI - The PICA approach.
    Int J Cardiol. 2023;370:445-446.
    >> Share

  261. PROENCA T, Pinto RA, Carvalho MM, Rocha A, et al
    Sex disparities and dyslipidemic control in a coronary rehabilitation program.
    Int J Cardiol. 2023;370:72-74.
    >> Share

  262. LAENENS D, van der Bijl P, Stassen J, Rossi AC, et al
    Introduction to hemodynamic forces by echocardiography.
    Int J Cardiol. 2023;370:442-444.
    >> Share

  263. SALAMANCA J, Garcia-Guimaraes M, Sabate M, Sanz-Ruiz R, et al
    Multivessel spontaneous coronary artery dissection: Clinical features, angiographic findings, management, and outcomes.
    Int J Cardiol. 2023;370:65-71.
    >> Share

  264. KAMBIC T, Sarabon N, Hadzic V, Lainscak M, et al
    Physical activity and sedentary behaviour following combined aerobic and resistance training in coronary artery disease patients: A randomised controlled trial.
    Int J Cardiol. 2023;370:75-79.
    >> Share

  265. LECHNER I, Reindl M, Reinstadler SJ
    Acute coronary syndrome without standard modifiable cardiovascular risk factors (SMuRF): More questions than answers.
    Int J Cardiol. 2023;370:409-410.
    >> Share

  266. RUSSO G, Pedicino D, Chiastra C, Vinci R, et al
    Coronary artery plaque rupture and erosion: Role of wall shear stress profiling and biological patterns in acute coronary syndromes.
    Int J Cardiol. 2023;370:356-365.
    >> Share

  267. D'ANCONA G, Massussi M, Savardi M, Signoroni A, et al
    Deep learning to detect significant coronary artery disease from plain chest radiographs AI4CAD.
    Int J Cardiol. 2023;370:435-441.
    >> Share

  268. SIMSEK B, Brilakis ES
    Reply to "Letter to the editor in response to the paper by Simsek et al. 2022".
    Int J Cardiol. 2023;370:177.
    >> Share

  269. ABOUL-HASSAN SS, Stankowski T, Marczak J, Perek B, et al
    Long-term outcomes of patients receiving right internal thoracic artery or radial artery as a second arterial conduit. A propensity score matching study.
    Int J Cardiol. 2023;370:136-142.
    >> Share

  270. ARCHILLETTI F, Ricci F, Pelliccia F, Dangas G, et al
    Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis.
    Int J Cardiol. 2023;370:122-128.
    >> Share

  271. GRIGORIAN-SHAMAGIAN L, Oteo JF, Gutierrez-Barrios A, Abdul-Jawad Altisent O, et al
    Endothelial dysfunction in patients with angina and non-obstructed coronary arteries is associated with an increased risk of mayor cardiovascular events. Results of the Spanish ENDOCOR registry.
    Int J Cardiol. 2023;370:18-25.
    >> Share

  272. QIU M, Luo F, Du L
    SMuRF-less ACS patients have higher risk of mortality?
    Int J Cardiol. 2023;370:83.
    >> Share

  273. SHOJI S, Kohsaka S, Kumamaru H, Nishimura S, et al
    Risk prediction models in patients undergoing percutaneous coronary intervention: A collaborative analysis from a Japanese administrative dataset and nationwide academic procedure registry.
    Int J Cardiol. 2023;370:90-97.
    >> Share

  274. NARDIN M, Pivato CA, Cao D, Sartori S, et al
    The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.
    Int J Cardiol. 2023;370:149-155.
    >> Share

  275. ABTAN J, Bhatt DL, Elbez Y, Ducrocq G, et al
    External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued
    Int J Cardiol. 2023;370:51-57.
    >> Share

  276. DI SERAFINO L, Barbato E, Serino F, Svanerud J, et al
    Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis.
    Int J Cardiol. 2023;370:84-89.
    >> Share

  277. GALLI M, Benenati S, Zito A, Capodanno D, et al
    Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis.
    Int J Cardiol. 2023;370:58-64.
    >> Share

  278. ARGIRO A, Zampieri M, Dei LL, Ferrantini C, et al
    Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
    Int J Cardiol. 2023;370:271-278.
    >> Share

    December 2022
  279. GALIMZHANOV A, Sabitov Y, Guclu E, Tenekecioglu E, et al
    Phenotyping for percutaneous coronary intervention and long-term recurrent weighted outcomes.
    Int J Cardiol. 2022 Dec 24:S0167-5273(22)01919.
    >> Share

  280. SU W, Song S, Dong H, Wu H, et al
    Identifying and comparing low-value care recommendations for coronary heart disease prevention, diagnosis, and treatment in the US and China.
    Int J Cardiol. 2022 Dec 22:S0167-5273(22)01915.
    >> Share

  281. XIN A, Li K, Yan LL, Chandramouli C, et al
    Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: A multi-center study.
    Int J Cardiol. 2022 Dec 21:S0167-5273(22)01918.
    >> Share

  282. ZUIN M, Rigatelli G, Battisti V, Costola G, et al
    Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Dec 16:S0167-5273(22)01914.
    >> Share

  283. MORONI F, Azzalini L, Caixeta A, Oliveira TP, et al
    TIMI flow and myocardial blushing after rescue PCI and cardiac magnetic resonance: Results from the Myocardial Salvage After Rescue Angioplasty: Evaluation by Magnetic Resonance (SAVE-ME) study.
    Int J Cardiol. 2022;369:77-79.
    >> Share

  284. OPSTAL TSJ, Nidorf SM, Fiolet ATL, Eikelboom JW, et al
    Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.
    Int J Cardiol. 2022 Dec 15:S0167-5273(22)01900.
    >> Share

  285. WANG C, Zhang M, Yan J, Wang R, et al
    Chemokine-like receptor 1 deficiency impedes macrophage phenotypic transformation and cardiac repair after myocardial infarction.
    Int J Cardiol. 2022 Dec 10:S0167-5273(22)01889.
    >> Share

  286. MORTBERG J, Salzinger B, Lundwall K, Edfors R, et al
    Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function.
    Int J Cardiol. 2022 Dec 4:S0167-5273(22)01876.
    >> Share

  287. PENG YW, Major T, Deatrick KB, Mohammed A, et al
    Nicorandil attenuates ventricular dysfunction and organ injury after cardiopulmonary bypass.
    Int J Cardiol. 2022;368:62-68.
    >> Share

  288. KAGEYAMA S, Serruys PW, Garg S, Ninomiya K, et al
    Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial.
    Int J Cardiol. 2022;368:28-38.
    >> Share

    November 2022
  289. DU Y, Yuan N, Yan J, Han G, et al
    Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01725.
    >> Share

  290. DASA O, Pepine CJ, Pearson TA
    An international perspective on low-dose aspirin for the primary prevention of myocardial infarction.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01723.
    >> Share

  291. GROENLAND FTW, Huang J, Scoccia A, Neleman T, et al
    Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction: Impact on treatment strategy and clinical outcome (FAST STEMI I study).
    Int J Cardiol. 2022 Nov 24:S0167-5273(22)01730.
    >> Share

  292. GARCIA-GUIMARAES M, Sanz-Ruiz R, Sabate M, Velazquez-Martin M, et al
    Spontaneous coronary artery dissection and ST-segment elevation myocardial infarction: Does clinical presentation matter?
    Int J Cardiol. 2022 Nov 23:S0167-5273(22)01720.
    >> Share

  293. YOON YH, Park GM, Lee JY, Lee JH, et al
    Relationship between sexual differences and cardiovascular risk factors in the prevalence of asymptomatic coronary disease.
    Int J Cardiol. 2022 Nov 19:S0167-5273(22)01709.
    >> Share

  294. JUNG C, Rezar R, Wischmann P, Masyuk M, et al
    The role of anemia on admission in acute coronary syndrome - An umbrella review of systematic reviews and meta-analyses.
    Int J Cardiol. 2022;367:1-10.
    >> Share

  295. GONZALEZ-DEL-HOYO M, Rodriguez-Leor O, Cid-Alvarez AB, de Prado AP, et al
    Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort.
    Int J Cardiol. 2022;367:90-98.
    >> Share

  296. HOLZKNECHT M, Lechner I, Reinstadler SJ
    The circadian clock in STEMI: A further contributor to the development of MVO?
    Int J Cardiol. 2022;367:115-116.
    >> Share

  297. WANG J, Li Y, Zhang S
    N(6)-methyladenosine modification: A vital role of programmed cell death in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;367:11-19.
    >> Share

  298. SIMSEK B, Jaffer FA, Kostantinis S, Karacsonyi J, et al
    Preprocedural coronary computed tomography angiography in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Int J Cardiol. 2022;367:20-25.
    >> Share

  299. ZUERCHER MD, Harvey DJ, Au LE, Shadyab AH, et al
    Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women.
    Int J Cardiol. 2022;367:99-104.
    >> Share

  300. BOERHOUT CKM, de Waard GA, Lee JM, Mejia-Renteria H, et al
    Combined use of hyperemic and non-hyperemic pressure ratios for revascularization decision-making: From the ILIAS registry.
    Int J Cardiol. 2022 Nov 11:S0167-5273(22)01702.
    >> Share

  301. DE LUCA L, Rosato S, D'Errigo P, Giordani B, et al
    Covid-19 diagnosis and mortality in patients with non-ST-elevation myocardial infarction admitted in Italy during the national outbreak.
    Int J Cardiol. 2022 Nov 7. pii: S0167-5273(22)01695.
    >> Share

  302. PICA S, Crimi G, Castelvecchio S, Pazzanese V, et al
    Cardiac magnetic resonance predictors of left ventricular remodelling following acute ST elevation myocardial infarction: The VavirimS study.
    Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01693.
    >> Share

  303. TORGUSON R, Mintz GS, Case BC, Di Mario C, et al
    Correlation between lipidic content and arterial-wall plaque burden: A Lipid Rich Plaque study sub-analysis.
    Int J Cardiol. 2022;366:32-34.
    >> Share

    October 2022
  304. PARK HW, Ozcan I, Toya T, Ahmad A, et al
    Invasive aortic pulse pressure is linked to cardiac allograft vasculopathy after heart transplantation.
    Int J Cardiol. 2022 Oct 29. pii: S0167-5273(22)01670.
    >> Share

  305. TRAUB J, Schurmann P, Schmitt D, Gassenmaier T, et al
    Features of metabolic syndrome and inflammation independently affect left ventricular function early after first myocardial infarction.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01653.
    >> Share

  306. DE FILIPPO O, D'Ascenzo F, Wojciech W, Leonardi S, et al
    IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01658.
    >> Share

  307. VANDENBRIELE C, Van Edom C, Tavazzi G
    Anticoagulant management for transition from failed thrombolysis to extra-corporeal membrane oxygenation in patients with high-risk pulmonary embolism: A thoughtful approach.
    Int J Cardiol. 2022 Oct 22. pii: S0167-5273(22)01649.
    >> Share

  308. RUSSO M, Jang IK
    Cholesterol crystals in atherosclerotic plaques: A future target to reduce the risk of plaque rupture?
    Int J Cardiol. 2022;365:30-31.
    >> Share

  309. MORRONE D, Gentile F, Aimo A, Cameli M, et al
    Perspectives in noninvasive imaging for chronic coronary syndromes.
    Int J Cardiol. 2022;365:19-29.
    >> Share

  310. HONTON B, Lipiecki J, Monsegu J, Leroy F, et al
    Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative.
    Int J Cardiol. 2022;365:106-111.
    >> Share

  311. BEREZIN AE
    Signature of standard modifiable CV factors as unrecognizable risk factor of in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2022 Oct 7. pii: S0167-5273(22)01479.
    >> Share

  312. FITZGERALD BT, Smith E, Scalia GM
    What are the prognostic implications and factors relating to exercise induced electrocardiographic ST segment changes in the setting of a non-ischemic stress echocardiogram?
    Int J Cardiol. 2022;364:157-161.
    >> Share

  313. QIN Z, Cao M, Xi X, Zhang Y, et al
    Cholesterol crystals in non-culprit plaques of STEMI patients: A 3-vessel OCT study.
    Int J Cardiol. 2022;364:162-168.
    >> Share

  314. COSENTINO N, Lucci C, Marenzi G
    Inflammation and left ventricular thrombosis after STEMI: Risk marker or risk factor?
    Int J Cardiol. 2022;364:16-17.
    >> Share

  315. YASUE H
    Coronary artery spasm: not rare but not fully understood yet.
    Int J Cardiol. 2022;364:18-19.
    >> Share

  316. WANG J, Li C, Ding D, Zhang M, et al
    Functional comparison of different jailed balloon techniques in treating non-left main coronary bifurcation lesions.
    Int J Cardiol. 2022;364:20-26.
    >> Share

    September 2022
  317. LI L, Tu B, Liu S, Zhang Z, et al
    Sex differences in ventricular arrhythmias epidemiology, risk factors, and mortality in congestive heart failure.
    Int J Cardiol. 2022 Sep 28. pii: S0167-5273(22)01415.
    >> Share

  318. DOMENICO T, Rita A, Giacomo S, Diego A, et al
    Salivary biomarkers for diagnosis of acute myocardial infarction: A systematic review.
    Int J Cardiol. 2022 Sep 24. pii: S0167-5273(22)01393.
    >> Share

  319. SAJID DS, Bokhari SFH
    Comment on "Single troponin measurement to rule-out acute myocardial infarction in early presenters".
    Int J Cardiol. 2022 Sep 21. pii: S0167-5273(22)01389.
    >> Share

  320. SOKHAL BS, Matetic A, Paul TK, Velagapudi P, et al
    Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01387.
    >> Share

  321. DENNIS M, Howpage S, McGill M, Dutta S, et al
    Myocardial fibrosis in Type 2 Diabetes is associated with functional and metabolomic parameters.
    Int J Cardiol. 2022;363:179-184.
    >> Share

  322. DI FUSCO SA, Cianfrocca C, Bisceglia I, Spinelli A, et al
    Potential pathophysiologic mechanisms underlying the inherent risk of cancer in patients with atherosclerotic cardiovascular disease.
    Int J Cardiol. 2022;363:190-195.
    >> Share

  323. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    >> Share

  324. YAMAMOTO T, Ishii T, Ishida A
    Impact of post physiological assessment after treatment for de novo coronary lesions using drug-coated balloons.
    Int J Cardiol. 2022;363:11-19.
    >> Share

  325. LIN HC, Chou SH, Fan PC, Zhu Z, et al
    The association between Day-1 urine cadmium excretion and 30-day mortality in patients with acute myocardial infarction: A multi-institutional cohort study.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01321.
    >> Share

  326. MICHELSEN HO, Henriksson P, Wallert J, Back M, et al
    Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The perfect-CR study.
    Int J Cardiol. 2022 Sep 8. pii: S0167-5273(22)01322.
    >> Share

  327. SHARMA A, Gupta I, Venkatesh U, Singh AK, et al
    E-cigarettes and myocardial infarction: A systematic review and Meta-analysis.
    Int J Cardiol. 2022 Sep 7. pii: S0167-5273(22)01315.
    >> Share

  328. RAM P, Shah S, Patel B, Osman M, et al
    Outcomes among heart transplant recipients following acute coronary syndrome: A Nationwide population based study.
    Int J Cardiol. 2022 Sep 5. pii: S0167-5273(22)01267.
    >> Share

  329. WIENEMANN H, Ameskamp C, Mejia-Renteria H, Mauri V, et al
    Diagnostic performance of quantitative flow ratio versus fractional flow reserve and resting full-cycle ratio in intermediate coronary lesions.
    Int J Cardiol. 2022;362:59-67.
    >> Share

  330. MATSUBAYASHI K, Soeda T
    Significance of superficial macrophage cluster in coronary atherosclerotic plaque.
    Int J Cardiol. 2022;362:24-25.
    >> Share

  331. STATHOGIANNIS K, Fearon WF
    Untangling diffuse CAD: Light at the end of the tunnel?
    Int J Cardiol. 2022;362:20-21.
    >> Share

  332. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Prevalence and outcomes of balloon undilatable chronic total occlusions: Insights from the PROGRESS-CTO.
    Int J Cardiol. 2022;362:42-46.
    >> Share

    August 2022
  333. DEMIRKIRAN A, van der Geest RJ, Hopman LHGA, Robbers LFHJ, et al
    Association of left ventricular flow energetics with remodeling after myocardial infarction: New hemodynamic insights for left ventricular remodeling.
    Int J Cardiol. 2022 Aug 22. pii: S0167-5273(22)01250.
    >> Share

  334. GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
    Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
    Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
    >> Share

  335. STAHLI BE, Witassek FF, Roffi M, Eberli FR, et al
    Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry.
    Int J Cardiol. 2022 Aug 19. pii: S0167-5273(22)01200.
    >> Share

  336. DE FILIPPO O, Russo C, Manai R, Borzillo I, et al
    Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
    Int J Cardiol. 2022 Aug 17. pii: S0167-5273(22)01201.
    >> Share

  337. MALHOTRA P, Han D
    Imaging tests for coronary artery disease risk assessment: Anatomy, physiology, or both?
    Int J Cardiol. 2022;361:124-125.
    >> Share

  338. GAUTHIER V, Montaye M, Ferrieres J, Kai SHY, et al
    Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries.
    Int J Cardiol. 2022;361:103-108.
    >> Share

  339. GALLINORO E, Almendarez M, Alvarez-Velasco R, Barbato E, et al
    Bioresorbable stents: Is the game over?
    Int J Cardiol. 2022;361:20-28.
    >> Share

  340. MYHRE PL, Rosjo H, Sarvari SI, Ukkonen H, et al
    Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome.
    Int J Cardiol. 2022;361:14-17.
    >> Share

  341. TANG LH, Harrison A, Skou ST, Taylor RS, et al
    Are patient characteristics and modes of delivery associated with completion of cardiac rehabilitation? A national registry analysis.
    Int J Cardiol. 2022;361:7-13.
    >> Share

  342. MARBACH JA, Faugno AJ, Pacifici S, Chweich H, et al
    Strategies to reduce limb ischemia in peripheral venoarterial extracorporeal membrane oxygenation: A systematic review and Meta-analysis.
    Int J Cardiol. 2022;361:77-84.
    >> Share

  343. LI Q, Xie E, Tu Y, Wu Y, et al
    Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2022 Aug 12. pii: S0167-5273(22)01193.
    >> Share

  344. CHEN Y, Wu J, Tang Y, Li Z, et al
    Multimorbidity and combined interventions for patients with coronary heart disease in Chinese population: Latent class analysis of a multi-center study.
    Int J Cardiol. 2022 Aug 10. pii: S0167-5273(22)01189.
    >> Share

  345. TSCHOPE C, Nelki V, Trippel TD, Klingel K, et al
    Safety and usefulness of left ventricular endomyocardial biopsy in new- onset acute heart failure requiring mechanical support by an Impella(R) device.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01176.
    >> Share

  346. GRAZIANI F, Lillo R, Biagini E, Limongelli G, et al
    Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01116.
    >> Share

  347. LIM HS
    How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01115.
    >> Share

  348. HWANG R, Peters R, Harmer E, Boyde M, et al
    Insight into a real-world experience with completion of cardiac rehabilitation.
    Int J Cardiol. 2022;360:5-6.
    >> Share

  349. GOEL V, Spear E, Cameron W, Thakur U, et al
    Breast arterial calcification and epicardial adipose tissue volume, but not density are independently associated with cardiovascular risk.
    Int J Cardiol. 2022;360:78-82.
    >> Share

  350. NAKAJIMA K, Yoshida S
    Small coronary artery matters: Non-dominant right coronary artery and perfusion imaging.
    Int J Cardiol. 2022;360:101-103.
    >> Share

  351. SEITZ A, Martinez Pereyra V, Hubert A, Klingel K, et al
    Epicardial and microvascular coronary artery spasm in biopsy-proven viral myocarditis.
    Int J Cardiol. 2022;360:1-4.
    >> Share

  352. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01120.
    >> Share

    July 2022
  353. DE LUCA G, Verdoia M, Morici N, Ferri LA, et al
    Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial.
    Int J Cardiol. 2022 Jul 27. pii: S0167-5273(22)01104.
    >> Share

  354. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    >> Share

  355. SEITZ A, Martinez Pereyra V, Sechtem U, Ong P, et al
    Update on coronary artery spasm 2022 - A narrative review.
    Int J Cardiol. 2022;359:1-6.
    >> Share

  356. DIXON LK, Akberali U, Di Tommaso E, George SJ, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022;359:20-27.
    >> Share

  357. NELEMAN T, Scoccia A, Masdjedi K, Tomaniak M, et al
    The prognostic value of angiography-based vessel fractional flow reserve after percutaneous coronary intervention: The FAST Outcome study.
    Int J Cardiol. 2022;359:14-19.
    >> Share

  358. ZHANG L, Fu Z, Huang Y, Luo W, et al
    LOXL1-AS1 alleviates inflammatory response in the epicardial adipose tissue with coronary artery disease by sponging miR-3614.
    Int J Cardiol. 2022;359:113.
    >> Share

  359. PRESCOTT E, Angeras O, Erlinge D, Grove EL, et al
    Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study.
    Int J Cardiol. 2022 Jul 13. pii: S0167-5273(22)01084.
    >> Share

  360. BONFIG NL, Soukup CR, Shah AA, Davidson S, et al
    Circadian dependence of microvascular obstruction during ST-segment elevation myocardial infarction.
    Int J Cardiol. 2022 Jul 8. pii: S0167-5273(22)01036.
    >> Share

  361. MPLANI V, Apostolopoulos D, Koufou E, Spyridonidis T, et al
    Inferior myocardial wall ischemia on SPECT-MPI in patients with non dominant right coronary artery and non significant coronary artery disease.
    Int J Cardiol. 2022;358:8-10.
    >> Share

  362. XU JJ, Cui J, Lin Q, Chen XY, et al
    Response to "Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury".
    Int J Cardiol. 2022;358:11.
    >> Share

  363. JAVAID A, Ahmed AI, Han Y, Al Rifai M, et al
    Incremental prognostic value of spect over CCTA.
    Int J Cardiol. 2022;358:120-127.
    >> Share

  364. YU K, Yang C, Liu J, Mo D, et al
    GATA2 might be used to predict the susceptibility of people to coronary artery disease.
    Int J Cardiol. 2022;358:94.
    >> Share

    June 2022
  365. ORBAN M, Kuehl A, Dischl D, Muller C, et al
    Fibrotic plaques in heart transplanted patients and their association with insulin resistance syndrome and Lp(a).
    Int J Cardiol. 2022 Jun 27. pii: S0167-5273(22)01015.
    >> Share

  366. BAKER HE, Tune JD, Mather KJ, Blaettner BS, et al
    Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na+/H+ exchanger-1.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01006.
    >> Share

  367. YAN H, Zhao N, Geng W, Hou Z, et al
    Pericoronary fat attenuation index and coronary plaque quantified from coronary computed tomography angiography identify ischemia-causing lesions.
    Int J Cardiol. 2022;357:8-13.
    >> Share

  368. KIM HO, Jiang B, Poon EKW, Thondapu V, et al
    High endothelial shear stress and stress gradient at plaque erosion persist up to 12 months.
    Int J Cardiol. 2022;357:1-7.
    >> Share

  369. HIGASHIOKA D, Shiono Y, Emori H, Khalifa AKM, et al
    Prevalence of myocardial perfusion scintigraphy derived ischemia in coronary lesions with discordant fractional flow reserve and non-hyperemic pressure ratios.
    Int J Cardiol. 2022;357:20-25.
    >> Share

  370. NGUYEN HL, Bui QT, Tran HV, Hoang MV, et al
    Characteristics, in-hospital management, and complications of acute myocardial infarction in northern and Central Vietnam.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00943.
    >> Share

  371. SUN M, Dube MP, Hennessy T, Schultz CJ, et al
    Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00926.
    >> Share

  372. SOLLI CN, Chamat-Hedemand S, Elming H, Ngo A, et al
    Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00928.
    >> Share

  373. CHOI YJ, Park MJ, Ko Y, Soh MS, et al
    Artificial intelligence versus physicians on interpretation of printed ECG images: Diagnostic performance of ST-elevation myocardial infarction on electrocardiography.
    Int J Cardiol. 2022 Jun 9. pii: S0167-5273(22)00869.
    >> Share

  374. MIR T, Uddin M, Changal K, Qureshi W, et al
    Mortality outcomes and 30-day readmissions associated with coronary artery aneurysms; a National Database Study.
    Int J Cardiol. 2022;356:6-11.
    >> Share

  375. ROONGSANGMANOON W, Wongsoasup A, Angkananard T, Rattanajaruskul N, et al
    Comparison of efficacy and safety of intracoronary nicardipine and adenosine for fractional flow reserve assessment of coronary stenosis.
    Int J Cardiol. 2022;356:1-5.
    >> Share

  376. KAVSAK PA, Mondoux SE, Ainsworth C, Worster A, et al
    High-sensitivity cardiac troponin and the importance of cutoffs in patients with prior coronary artery bypass grafting with suspected NSTEMI.
    Int J Cardiol. 2022;356:36-37.
    >> Share

  377. AKIMARU K, Iwabuchi M, Ishida A, Uehara H, et al
    Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention.
    Int J Cardiol. 2022;356:30-35.
    >> Share

  378. SIMONI AH, Frydenlund J, Kragholm KH, Boggild H, et al
    Socioeconomic inequity in incidence, outcomes and care for acute coronary syndrome: A systematic review.
    Int J Cardiol. 2022;356:19-29.
    >> Share

    May 2022
  379. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    >> Share

  380. PIVATO CA, Chandiramani R, Petrovic M, Nicolas J, et al
    Depression and ischemic heart disease.
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00767.
    >> Share

  381. TRAVERSE JH
    When should patients with acute myocardial infarction undergo CABG? A question much in need of a randomized clinical trial?
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00768.
    >> Share

  382. BERNARDI M, Spadafora L, Biondi-Zoccai G, Giordano A, et al
    Juvenile myocardial infarction: Sex matters.
    Int J Cardiol. 2022 May 23. pii: S0167-5273(22)00757.
    >> Share

  383. FLORIAN A
    Predicting LV thrombosis after acute myocardial infarction: From Virchow's triad to state-of-the-art cardiovascular magnetic resonance imaging.
    Int J Cardiol. 2022 May 18. pii: S0167-5273(22)00745.
    >> Share

  384. LI Q, Li Z, Li T, Liu C, et al
    Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;355:44.
    >> Share

  385. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Effects of left ventricular mass on computed tomography derived fractional flow reserve in significant obstructive coronary artery disease.
    Int J Cardiol. 2022;355:59-64.
    >> Share

  386. HOLZKNECHT M, Reinstadler SJ
    CRP: a potential target in reperfused STEMI? Reply to the letter: "Targeting CRP in microvascular obstruction after PCI".
    Int J Cardiol. 2022;355:5.
    >> Share

  387. DIEU X, Chabrun F, Prunier F, Angoulvant D, et al
    Post-infarct cardiac remodeling predictions with machine learning.
    Int J Cardiol. 2022;355:1-4.
    >> Share

  388. SVARTSTEIN AW, Lassen MH, Skaarup KG, Grove GL, et al
    Predictive value of left atrial strain in relation to atrial fibrillation following acute myocardial infarction.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00736.
    >> Share

  389. SHETTY MK, Kunal S, Girish MP, Qamar A, et al
    Machine learning based model for risk prediction after ST-Elevation myocardial infarction: Insights from the North India ST elevation myocardial infarction (NORIN-STEMI) Registry.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00734.
    >> Share

  390. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00660.
    >> Share

  391. IANNACCONE M, Franchin L, Hanson ID, Boccuzzi G, et al
    Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00662.
    >> Share

  392. MA F, Hao J, Zhao J, Liu DY, et al
    Circulating FAM19A5 level is associated with the presence and severity of coronary artery disease.
    Int J Cardiol. 2022;354:50-55.
    >> Share

  393. GRAGNANO F, Cesaro A, Pelliccia F, Limongelli G, et al
    Early-onset MINOCA: Prognostic implications and considerations for practice.
    Int J Cardiol. 2022;354:14-16.
    >> Share

  394. HITOMI Y, Masaki N, Ishinoda Y, Ido Y, et al
    Effectiveness of the d-ROMs oxidative stress test to predict long-term cardiovascular mortality.
    Int J Cardiol. 2022;354:43-47.
    >> Share

  395. KOECHLIN L, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, et al
    Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting.
    Int J Cardiol. 2022;354:1-6.
    >> Share

    April 2022
  396. WANG Z, Li T, Li M, Gu W, et al
    MALAT1 aggravates cardiomyocytes injury in myocardial infarction by sponging miR-135b.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00636.
    >> Share

  397. LI J, Chen R, Zhou J, Wang Y, et al
    The relationship between Hemoglobin A1c and the maximal plaque stress of culprit ruptured plaques in patients with ST-segment elevated myocardial infarction.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00634.
    >> Share

  398. BENEDETTO U, Sinha S, Mulla A, Glampson B, et al
    Implications of elevated troponin on time-to-surgery in non-ST elevation myocardial infarction (NIHR Health Informatics Collaborative: TROP-CABG study).
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00586.
    >> Share

  399. FERRELL MC, Elizabeth Garrett BA, Alicia Tomlin DO, Cole Wayant DO, et al
    Editorial conflicts of interest related to the Management of Stable Ischemic Heart Disease.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00569.
    >> Share

  400. ORBAN M, Dietl M, Dischl D, von Samson-Himmelstjerna P, et al
    Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomography.
    Int J Cardiol. 2022 Apr 18. pii: S0167-5273(22)00556.
    >> Share

  401. CAO M, Luo H, Li D, Wang S, et al
    Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases.
    Int J Cardiol. 2022;353:109-117.
    >> Share

  402. SCICALI R
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease.
    Int J Cardiol. 2022;353:118.
    >> Share

  403. ZHAO Z, Shi Q, Guo Q, Peng L, et al
    Remote ischemic preconditioning can extend the tolerance to extended drug-coated balloon inflation time by reducing myocardial damage during percutaneous coronary intervention.
    Int J Cardiol. 2022;353:3-8.
    >> Share

  404. D'ASCENZO F, Elia E, de Filippo O, Manai R, et al
    Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry.
    Int J Cardiol. 2022;353:9-14.
    >> Share

  405. NANDHAKUMAR V, Pakshirajan B, Chopra A, Anandan H, et al
    Safety and feasibility of intravascular ultrasound guided zero-contrast percutaneous coronary intervention-A prospective study.
    Int J Cardiol. 2022;353:22-28.
    >> Share

  406. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    >> Share

  407. BOTTO GL, Mantovani LG, Cortesi PA, De Ponti R, et al
    The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00483.
    >> Share

  408. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    >> Share

  409. ONG P, Allgauer S
    Factors influencing medical care of STEMI patients during the COVID-19 pandemic worldwide.
    Int J Cardiol. 2022;352:195-196.
    >> Share

  410. LV R, Wang L, Maehara A, Guo X, et al
    Image-based biomechanical modeling for coronary atherosclerotic plaque progression and vulnerability prediction.
    Int J Cardiol. 2022;352:1-8.
    >> Share

  411. VYNCKIER P, Kotseva K, Gevaert S, De Bacquer D, et al
    Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry.
    Int J Cardiol. 2022;352:152-157.
    >> Share

  412. GALLINORO E, Monizzi G, Sonck J, Candreva A, et al
    Physiological and angiographic outcomes of PCI in calcified lesions after rotational atherectomy or intravascular lithotripsy.
    Int J Cardiol. 2022;352:27-32.
    >> Share

  413. ZHANG D, Wu H, Liu D, Li Y, et al
    Targeting CRP in microvascular obstruction after PCI.
    Int J Cardiol. 2022;352:124.
    >> Share

  414. ZHANG R, Xu B, Dou K, Guan C, et al
    Post-PCI outcomes predicted by pre-intervention simulation of residual quantitative flow ratio using augmented reality.
    Int J Cardiol. 2022;352:33-39.
    >> Share

  415. SCHAFER A
    Clopidogrel or ticagrelor in elderly patients with acute coronary syndromes - Nihil nocere!
    Int J Cardiol. 2022;352:19-20.
    >> Share

  416. VAN BEEK KAJ, van Steenbergen GJ, Vervaat FE, Mulders BCJH, et al
    Single center experience in the treatment of hemodynamically significant diffuse coronary artery disease of the left anterior descending.
    Int J Cardiol. 2022;352:40-44.
    >> Share

  417. MASCI PG, Bogaert J
    Implementing the risk stratification in STEMI by cardiovascular magnetic resonance: An academic exercise or real benefit?
    Int J Cardiol. 2022;352:188-189.
    >> Share

    March 2022
  418. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    >> Share

  419. ZHANG Y
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
    >> Share

  420. GONZALEZ FERRERO T, Alvarez Alvarez B, Cordero A, Martinon Martinez J, et al
    Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry.
    Int J Cardiol. 2022;351:8-14.
    >> Share

  421. DEMIRCI D, Demirci DE, Chi G
    Association between obesity grade and the age of the first acute coronary syndrome: Prospective observational study.
    Int J Cardiol. 2022;351:93-99.
    >> Share

  422. REINSTADLER SJ, Dlaska C, Reindl M, Marks M, et al
    Predicting cardiac remodeling after myocardial infarction with machine learning: are we there yet?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00335.
    >> Share

  423. BRUNO F, Moirano G, Budano C, Lalloni S, et al
    Incidence trends and long-term outcomes of myocardial infarction in young adults: Does gender matter?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00331.
    >> Share

  424. CIFKOVA R
    Gender differences in secondary prevention of coronary heart disease: Far from closing the gap.
    Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00322.
    >> Share

  425. MONTINARI MR, Minelli P, Russo A, Gianicolo E, et al
    Patterns of coronary heart disease mortality in Italy from 1931 to 2015 and a focus on a region with highly industrialized areas.
    Int J Cardiol. 2022 Mar 9. pii: S0167-5273(22)00326.
    >> Share

  426. ZANCHIN C, Ledwoch S, Bar S, Ueki Y, et al
    Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventions.
    Int J Cardiol. 2022;350:1-8.
    >> Share

  427. PENG J, Xing CY, Zhao K, Deng J, et al
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease: A case-control study.
    Int J Cardiol. 2022;350:9-15.
    >> Share

  428. MATSUI S, Maruhashi T, Kishimoto S, Kajikawa M, et al
    Poor tooth brushing behavior is associated with high risk of cardiovascular events: A prospective observational study.
    Int J Cardiol. 2022;350:111-117.
    >> Share

  429. WU J, Huang Y, Zhang J, Xiang Z, et al
    LncRNA CPhar mediates exercise-induced cardioprotection by promoting eNOS phosphorylation at Ser1177 via DDX17/PI3K/Akt pathway after MI/RI.
    Int J Cardiol. 2022;350:16.
    >> Share

    February 2022
  430. LU Y, Tian Y, Mou T, Zhou Y, et al
    Transient cardioprotective effects of remote ischemic postconditioning on non-reperfused myocardial infarction: longitudinal evaluation study in pigs.
    Int J Cardiol. 2022 Feb 18. pii: S0167-5273(22)00257.
    >> Share

  431. TILLER C, Reindl M, Reinstadler SJ, Klug G, et al
    The classical 12lead ECG: Much more to offer than just a diagnosis in STEMI?
    Int J Cardiol. 2022;349:29-30.
    >> Share

  432. FUJISUE K, Yamamoto E, Sueta D, Takae M, et al
    Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome.
    Int J Cardiol. 2022;349:1-6.
    >> Share

  433. FERRO A
    Antithrombotic therapy after 1 year of dual antiplatelet therapy following acute coronary syndrome: What to do?
    Int J Cardiol. 2022;349:27-28.
    >> Share

  434. SAITO Y, Saito Y, Kato K, Kobayashi Y, et al
    Gender differences in factors associated with vasospastic angina.
    Int J Cardiol. 2022;349:7-11.
    >> Share

  435. MAGNANI G, Bricoli S, Ardissino M, Maglietta G, et al
    Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00249.
    >> Share

  436. FAGA V, Anguera I, Oloriz T, Nombela-Franco L, et al
    Improved prediction of electrical storm in patients with prior myocardial infarction and implantable cardioverter defibrillator.
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00251.
    >> Share

  437. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
    >> Share

  438. MARENGO G, De Filippo O, D'Ascenzo F, Iannaccone M, et al
    IVUS guided PCI in patients with acute myocardial infarction - The route toward a "plaque oriented" PCI.
    Int J Cardiol. 2022 Feb 11. pii: S0167-5273(22)00246.
    >> Share

  439. GIRERD N
    The growing importance of heart failure in myocardial infarction.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
    >> Share

  440. HOLZKNECHT M, Klug G, Metzler B, Reinstadler SJ, et al
    Mechanical complications after STEMI: Another collateral damage of the COVID-19 pandemic.
    Int J Cardiol. 2022;348:23-25.
    >> Share

  441. ASAKURA K, Minami Y, Kinoshita D, Katamine M, et al
    Impact of triglyceride levels on plaque characteristics in patients with coronary artery disease.
    Int J Cardiol. 2022;348:134-139.
    >> Share

  442. XU X, Fam JM, Low AFH, Tan RS, et al
    Sex differences in assessing stenosis severity between physician visual assessment and quantitative coronary angiography.
    Int J Cardiol. 2022;348:9-14.
    >> Share

  443. ALFONSO F, Rivero F, Cortese B
    Excimer laser prior to drug-coated balloon treatment of in-stent restenosis.
    Int J Cardiol. 2022;348:47-49.
    >> Share

  444. ORSINI E, Marzilli M, Zito GB, Carbone V, et al
    Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study.
    Int J Cardiol. 2022 Feb 1. pii: S0167-5273(22)00182.
    >> Share

    January 2022
  445. FU EL, Clase CM, Janse RJ, Lindholm B, et al
    Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00131.
    >> Share

  446. GROENLAND FTW, Neleman T, Kakar H, Scoccia A, et al
    Intravascular ultrasound-guided versus coronary angiography-guided percutaneous coronary intervention in patients with acute myocardial infarction: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Jan 15. pii: S0167-5273(22)00068.
    >> Share

  447. ADLAM D, Zarebinski M, Uren NG, Ptaszynski P, et al
    A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
    Int J Cardiol. 2022;347:1-7.
    >> Share

  448. PERFETTI M, Di Nicola M, Zimarino M
    Asimmetric uncertainties and account balance. Editorial to "Instantaneous wave-free ratio compared with fractional flow 2 reserve in PCI: A cost-minimization analysis".
    Int J Cardiol. 2022;347:19-20.
    >> Share

  449. KHAN E, Lambrakis K, Nazir SA, Chuang A, et al
    Implementation of more sensitive cardiac troponin T assay in a state-wide health service.
    Int J Cardiol. 2022;347:66-72.
    >> Share

  450. MA P, Liu J, Hu Y, Zhou X, et al
    Histologic validation of stress cardiac magnetic resonance T1-mapping techniques for detection of coronary microvascular dysfunction in rabbits.
    Int J Cardiol. 2022;347:76-82.
    >> Share

  451. GUECKEL J, Puelacher C, Glarner N, Gualandro DM, et al
    Patient- and procedure-related factors in the pathophysiology of perioperative myocardial infarction/injury.
    Int J Cardiol. 2022 Jan 11. pii: S0167-5273(22)00062.
    >> Share

  452. WU Z, Cheng S, Wang S, Li W, et al
    C-MYC ameliorates ventricular remodeling of myocardial infarction rats via binding to the promoter of microRNA-29a-3p to facilitate TET2 expression.
    Int J Cardiol. 2022 Jan 8. pii: S0167-5273(22)00067.
    >> Share

  453. HU M, Lu Y, Wan S, Li B, et al
    Long-term outcomes in inferior ST-segment elevation myocardial infarction patients with right ventricular myocardial infarction.
    Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00003.
    >> Share

  454. GIBSON CM, Mehta S, Ceschim MRS, Frauenfelder A, et al
    Evolution of single-lead ECG for STEMI detection using a deep learning approach.
    Int J Cardiol. 2022;346:47-52.
    >> Share

  455. FERRANNINI E, Marx N, Andreini D, Campi B, et al
    Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance.
    Int J Cardiol. 2022;346:86-92.
    >> Share

  456. GATTO L, Alfonso F, Paoletti G, Burzotta F, et al
    Relationship betweeen the amount and location of macrophages and clinical outcome: subanalysis of the CLIMA-study.
    Int J Cardiol. 2022;346:8-12.
    >> Share

    December 2021
  457. KUCHARSKA-NEWTON AM, Loop MS, Bullo M, Moore C, et al
    Use of troponins in the classification of myocardial infarction from electronic health records. The Atherosclerosis Risk in Communities (ARIC) Study.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02014.
    >> Share

  458. DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
    Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
    >> Share

  459. ZEITZ C
    Relieving angina - interplay between gender, pathophysiology and medication efficacy.
    Int J Cardiol. 2021;345:20-21.
    >> Share

  460. CESARO A, Gragnano F, Calabro P, Moscarella E, et al
    Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.
    Int J Cardiol. 2021;345:7-13.
    >> Share

  461. TAKAHASHI J, Shimokawa H, Yasuda S
    Usefulness of hybrid assessment for coronary functional abnormalities by non-invasive and invasive techniques.
    Int J Cardiol. 2021;345:24-25.
    >> Share

  462. GALLI M, Franchi F
    Guided selection of antiplatelet therapy in acute coronary syndrome: Impact on outcomes and resource utilization.
    Int J Cardiol. 2021;345:36-38.
    >> Share

  463. AHN JH, Ahn Y, Jeong MH, Kim JH, et al
    Optimal low-density lipoprotein cholesterol target level in Korean acute myocardial infarction patients (<70mg/dL vs. <55mg/dL): Based on Korea acute myocardial infarction registry-National Institute of Health.
    Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02012.
    >> Share

  464. MEHTA PK, Quesada O, Al-Badri A, Fleg J, et al
    Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.
    Int J Cardiol. 2021 Dec 10. pii: S0167-5273(21)02005.
    >> Share

  465. YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
    Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
    >> Share

  466. ANANTHAKRISHNA R, Liang Z, Raman B, Moran JL, et al
    Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01979.
    >> Share

  467. LEMESLE G, Bauters C, Bonello L, Fauchier L, et al
    Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01966.
    >> Share

  468. TSUJITA K
    Realistic detection of natural history of early coronary atherosclerosis: Best part of computed tomography-derived fractional flow reserve?
    Int J Cardiol. 2021;344:34-35.
    >> Share

  469. BERNTORP K, Persson J, Koul SM, Patel MR, et al
    Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis.
    Int J Cardiol. 2021;344:54-59.
    >> Share

  470. RIJLAARSDAM-HERMSEN D, van Domburg RT, Deckers JW, Kuijpers D, et al
    Comparison of guidelines for diagnosing suspected stable angina and the additional value of the calcium score.
    Int J Cardiol. 2021;344:1-7.
    >> Share

    November 2021
  471. TANG Y, Liu S, Shi Y, He T, et al
    Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction.
    Int J Cardiol. 2021 Nov 24. pii: S0167-5273(21)01861.
    >> Share

  472. MARCOS-GARCES V, Perez N, Gavara J, Lopez-Lereu MP, et al
    Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01866.
    >> Share

  473. GORIKI Y, Yoshioka G, Natsuaki M, Shinzato K, et al
    Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01862.
    >> Share

  474. HENG GE
    Is diastolic dysfunction a new windsock in the risk stratification of patients with coronary heart disease?
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01853.
    >> Share

  475. DESEIVE S, Orban M
    Choosing the right potent P2Y12-receptor inhibitor in East Asians with acute myocardial infarction and percutaneous coronary intervention - Editorial on Ticagrelor versus Prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 16. pii: S0167-5273(21)01848.
    >> Share

  476. TANG LH, Harrison A, Skou ST, Doherty P, et al
    To what extent are comorbidity profiles associated with referral and uptake to cardiac rehabilitation.
    Int J Cardiol. 2021;343:85-91.
    >> Share

  477. DIXON LK, Di Tommaso E, Dimagli A, Sinha S, et al
    Impact of sex on outcomes after cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2021;343:27-34.
    >> Share

  478. PYXARAS SA, Harmel EK
    Artificial intelligence for the assessment of coronary artery disease- The dawn of a new era?
    Int J Cardiol. 2021;343:3-4.
    >> Share

  479. FENDER AC, Dobrev D
    Nitric oxide as a fragile switch between cardioprotection and cardiac injury.
    Int J Cardiol. 2021;343:102-103.
    >> Share

  480. NAKAJIMA A, Subban V, Russo M, Bryniarski KL, et al
    Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study.
    Int J Cardiol. 2021;343:171-179.
    >> Share

  481. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Impact of vascular morphology and plaque characteristics on computed tomography derived fractional flow reserve in early stage coronary artery disease.
    Int J Cardiol. 2021;343:187-193.
    >> Share

  482. JENSCH PJ, Stiermaier T, Reinstadler SJ, Feistritzer HJ, et al
    Prognostic relevance of peri-infarct zone measured by cardiovascular magnetic resonance in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01785.
    >> Share

  483. BANG C, Lauridsen KG, Andersen CF, Lofgren B, et al
    Reply to the Letter to the Editor: "Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?"
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01761.
    >> Share

  484. SOFI F, Dinu M, Reboldi G, Stracci F, et al
    Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01765.
    >> Share

  485. XU JJ, Cui J, Lin Q, Chen XY, et al
    Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;342:82-93.
    >> Share

  486. TRAVERSE JH
    The coronary sinus reducer - Where modern technology meets old school physiology!
    Int J Cardiol. 2021;342:31-32.
    >> Share

  487. COOK CM, Howard JP, Ahmad Y, Shun-Shin MJ, et al
    Comparing invasive hemodynamic responses in adenosine hyperemia versus physical exercise stress in chronic coronary syndromes.
    Int J Cardiol. 2021;342:7-14.
    >> Share

  488. LI KS, Bai Y, Li J, Li SL, et al
    LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway.
    Int J Cardiol. 2021;342:72-81.
    >> Share

    October 2021
  489. HAN X, Chen Z, Wang Y, Zhang J, et al
    Prognostic significance of QRS distortion and frontal QRS-T angle in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2021 Oct 26. pii: S0167-5273(21)01693.
    >> Share

  490. BOUISSET F, Deney A, Ferrieres J, Panagides V, et al
    Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay.
    Int J Cardiol. 2021 Oct 23. pii: S0167-5273(21)01574.
    >> Share

  491. ONO M, Kawashima H, Hara H, Mancone M, et al
    Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.
    Int J Cardiol. 2021;341:9-12.
    >> Share

  492. WEBB CM, Collins P
    Medical management of anginal symptoms in women with stable angina pectoris: A systematic review of randomised controlled trials.
    Int J Cardiol. 2021;341:1-8.
    >> Share

  493. GIOVANNINI M, Koniari I, Mori F, Barni S, et al
    Kounis syndrome: Towards a new classification.
    Int J Cardiol. 2021;341:13-14.
    >> Share

  494. CHALIKIAS G, Tziakas DN
    Triggering receptor expressing on myeloid cells (TREM)-1 and acute myocardial infarction: An association vs. causality conundrum.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01507.
    >> Share

  495. CHIANG CH, Chiang CH, Chiang CH
    Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01388.
    >> Share

  496. PARK S, Kim YG, Ann SH, Park HW, et al
    Ticagrelor versus prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Oct 4. pii: S0167-5273(21)01505.
    >> Share

  497. ARCHILLETTI F, Zimarino M
    Intravascular ultrasound for in-stent restenosis: A problem well stated is half-solved.
    Int J Cardiol. 2021;340:22-23.
    >> Share

  498. GUO Y, Li Q, Xuan YT, Wu WJ, et al
    Exercise-induced late preconditioning in mice is triggered by eNOS-dependent generation of nitric oxide and activation of PKCepsilon and is mediated by increased iNOS activity.
    Int J Cardiol. 2021;340:68-78.
    >> Share

  499. YONG ASC, Pargaonkar VS, Wong CCY, Javadzdegan A, et al
    Abnormal shear stress and residence time are associated with proximal coronary atheroma in the presence of myocardial bridging.
    Int J Cardiol. 2021;340:7-13.
    >> Share

  500. SHLOFMITZ E, Torguson R, Zhang C, Mintz GS, et al
    Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).
    Int J Cardiol. 2021;340:17-21.
    >> Share

    September 2021
  501. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    >> Share

  502. REINDL M, Lechner I, Reinstadler SJ, Metzler B, et al
    Transient STEMI - No STEMI at all?
    Int J Cardiol. 2021;339:12-13.
    >> Share

  503. ISHIHARA T, Dohi T, Nakamura D, Kikuchi A, et al
    Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment.
    Int J Cardiol. 2021;339:28-32.
    >> Share

  504. LIU H, Bi K, Hu Y
    Targeting vimentin in coronary artery disease.
    Int J Cardiol. 2021;339:144.
    >> Share

  505. JANG WJ, Park IH, Yang JH, Chun WJ, et al
    Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry.
    Int J Cardiol. 2021;339:70-74.
    >> Share

  506. ANGELINI P, Uribe C
    Where's the beef in anomalous coronary artery origin from an opposite aortic sinus?
    Int J Cardiol. 2021;339:45-46.
    >> Share

  507. ZORZI A, Brunetti G, Cardaioli F, D'Arcangelo F, et al
    Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.
    Int J Cardiol. 2021;339:219-224.
    >> Share

    August 2021
  508. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    >> Share

    July 2021
  509. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016